Sex Differences in the Impact of Social Determinants of Health on Substance Use Disorder Treatment Outcomes | Research Square window.SnipcartSettings = { analytics: { enabled: false } }; (function() { var accessVector = localStorage.getItem('access_vector') || ''; window.dataLayer = window.dataLayer || []; if (accessVector) { window.dataLayer.push({ user: { profile: { profileInfo: { snid: accessVector } } } }); } })(); (function(w,d,s,l,i){w[l]=w[l]||[];w[l].push({'gtm.start':new Date().getTime(),event:'gtm.js'});var f=d.getElementsByTagName(s)[0],j=d.createElement(s),dl=l!='dataLayer'?'&l='+l:'';j.async=true;j.src='https://www.googletagmanager.com/gtm.js?id='+i+dl;f.parentNode.insertBefore(j,f);})(window,document,'script','dataLayer','GTM-K279D39R'); Browse Preprints In Review Journals COVID-19 Preprints AJE Video Bytes Research Tools Research Promotion AJE Professional Editing AJE Rubriq About Preprint Platform In Review Editorial Policies Our Team Advisory Board Help Center Sign In Submit a Preprint Cite Share Download PDF Research Article Sex Differences in the Impact of Social Determinants of Health on Substance Use Disorder Treatment Outcomes C. Leonardo Jimenez Chavez, MacKenzie R. Peltier, Sherry A. McKee This is a preprint; it has not been peer reviewed by a journal. https://doi.org/ 10.21203/rs.3.rs-6422698/v1 This work is licensed under a CC BY 4.0 License Status: Published Journal Publication published 22 Jul, 2025 Read the published version in Biology of Sex Differences → Version 1 posted 7 You are reading this latest preprint version Abstract Background: Social determinants of health (SDOH) and clinical severity factors are known to shape substance use disorder (SUD) treatment outcomes, yet limited research has explored how these influences differ by sex. Understanding these differences is important to improving treatment equity and outcomes in publicly funded treatment systems. Methods: This study analyzed data from the 2018–2022 Treatment Episode Data Set – Discharges (TEDS-D), a national dataset of adults discharged from publicly funded SUD treatment programs. Sex-stratified binary logistic regressions were used to examine predictors of two outcomes: treatment non-completion and substance use at discharge. Predictors included SDOH (i.e., employment, education level, housing status, criminal justice involvement, prior treatment history, marital status, health insurance coverage and treatment duration) and indicators of SUD severity (e.g., age at first use, polysubstance use, and co-occurring psychiatric disorders). Results: Both SDOH and clinical severity indicators were significantly associated with poorer treatment outcomes, with distinct patterns by sex. Women showed more consistent risk for poor treatment outcomes across predictors, including unemployment, psychiatric comorbidities, and polysubstance use, while lack of prior treatment history was the strongest predictor of substance use at discharge and dropout for men. Other predictors, such as housing instability, criminal justice involvement, and later-onset substance use, were also associated with increased risk of non-abstinence and dropout, with notable sex differences. Health insurance coverage was associated with better outcomes for both sexes, with the protective effect more consistent in women. Conclusions: These findings emphasize the need for sex-informed treatment approaches that address both social determinants of health and clinical complexity. Tailoring care to the unique risks and contexts of men and women may improve retention and reduce substance use at discharge, particularly in publicly funded systems. Sex Differences Social Determinants of Health Substance Use Disorder Treatment Outcomes Community Treatment PLAIN ENGLISH SUMMARY Substance use treatment is not a one-size-fits-all process. Recovery is shaped by both structural challenges, such as housing instability or limited access to care, and the clinical severity of substance use. These factors influence whether someone completes treatment and stays abstinent, and they often affect men and women in different ways. In this study, we examined over 7 million episodes of publicly funded substance use treatment programs from across the United States. We looked at how social determinants of health (e.g. employment status, education, housing, access to treatment) and clinical factors (e.g. age of substance use onset, psychiatric comorbidities and polysubstance use), were associated with two key outcomes: whether a person completed treatment and whether they reported using substance at the end of care. We found that women often faced greater challenges, especially regarding unstable housing, co-occurring mental health conditions and using more than one type of substance. For men, being new to treatment was a strong predictor of poorer treatment success. These findings demonstrate the need for treatment programs to offer support that meets men and women where they are, considering the different barriers and challenges each group may face along the path to sustained recovery. HIGHLIGHTS We examined social determinants of health (SDOH) and substance use disorder (SUD) severity-related predictors of substance use and treatment completion in a national sample of over 7 million adults. Women demonstrated more consistent vulnerability across predictors, including unemployment, co-occurring psychiatric disorders, and polysubstance use. For men, lack of prior treatment for SUD was the most consistent predictor for substance use at discharge and treatment dropout. Housing instability, access to healthcare, and financial barriers showed sex-specific effects, with women generally experiencing great risk of unsuccessful treatment. Findings highlight the importance of improving SUD care to address sex-specific risks and structural barriers, especially in publicly funded systems. BACKGROUND Substance Use Disorders (SUDs) are a major global public health concern, contributing to significant health and social burdens that affect millions of individuals, their families and their communities. In the United States, estimates from the Substance Abuse and Mental Health Services Administration (SAMHSA) approximate that nearly 18% of the population had an SUD diagnosis in 2023 (SAMHSA, 2024). While treatment improves SUD outcomes, 76% of individuals with SUD did not receive treatment (SAMHSA, 2024). There are numerous barriers to treatment which are influenced by both individual and structural factors, including social determinants of health (SDOH). SDOH are nonmedical conditions in which people are born, grow, live, work, worship and age that influence a wide range of health and quality-of-life outcomes and risks (Centers for Disease Control and Prevention [CDC], 2023). These factors include employment, education, housing stability, healthcare access, and criminal justice involvement. Studies have demonstrated improved SUD treatment outcomes, including increased retention and reduced substance use, when interventions reduce social stressors and provide recovery support (Amaro et al., 2021 ; Polcin & Korcha, 2017 ). Employment status and social support, for example, are strong predictors of better retention in treatment and long-term abstinence (Lin et al., 2024 ). Conversely, individuals who face unemployment, homelessness, or social isolation exhibit a greater risk of non-abstinence (Lin et al., 2024 ). Involvement with the criminal justice system is also associated with worse treatment outcomes, disrupting treatment continuity and disproportionately overwhelming marginalized groups (Peacock et al., 2018 ). The influence of SDOH is particularly evident in publicly funded SUD treatment programs, which often serve the most socioeconomically disadvantaged populations. Individuals in these programs frequently face financial instability, lack of reliable transportation, and limited healthcare access, all factors that hinder treatment retention (Acevedo et al., 2018 ). Efforts to address these social challenges have demonstrated promise in improving engagement in treatment programs and reducing post-treatment drug use (Redeł et al., 2024 ; Chan et al., 2021 ). Sex differences further influence how SDOH play a role in SUD treatment outcomes. Women often face compounding structural and social barriers, including childcare responsibilities, financial dependence, intimate partner violence and stigma, that all impact women’s ability to remain engaged in treatment (Ogden, Dichter & Bazzi, 2022 ; McHugh et al., 2018 ; Greenfield et al., 2007 ). These challenges not only impede treatment continuity but can also interfere with the overall progress to abstinence. Conversely, men are more likely to be involved in the legal system and have higher rates of polysubstance use, factors that shape both access to and outcomes of treatment (Goodwin et al., 2022 ; Shaffer et al., 2019 ). Additionally, employment and economic stability play a larger role in treatment retention for men, as job loss or financial instability is a consistent reason for treatment discontinuity (Parlier-Ahmad et al., 2022 ). Despite these well-documented sex differences, research examining the interaction between SDOH and sex in shaping treatment trajectories remains limited. In addition to SDOH, substance use severity characteristics also significantly impact treatment outcomes. Variables including age at first use, psychiatric comorbidities and polysubstance use, serve as important predictors of treatment success. An earlier age of first use is associated with increased SUD severity and poorer treatment outcomes (Chi et al., 2014 ). Psychiatric comorbidities further complicate treatment, as individuals with existing dual diagnoses are reported to have a greater likelihood of continued use and treatment non-completion (Krawczyk et al., 2017 ), with women in particular showing higher rates of co-occurring conditions, which further complicate treatment adherence and delay recovery (McHugh et al., 2018 ). Polysubstance use also presents additional treatment challenges, often requiring more robust and long-term interventions (Bhalla et al., 2017 ). While these severity-related factors play a role in influencing treatment outcomes, their interplay with SDOH and interaction with sex remains unclear, thus highlighting the need for a large-scale, data-driven approach to investigate the influence of both SDOH and SUD severity-related factors of treatment outcomes across sexes. To address this gap in the literature, the present study uses data from the national Treatment Episode Data Set – Discharges (TEDS-D), a dataset of annual SUD treatment discharges reported by SAMHSA. TEDS-D provides extensive information on patient demographics, social and economic indicators, substance use history, medical and treatment history and discharge status from individuals discharged from publicly funded SUD treatment programs across the United States. Using this comprehensive dataset, we investigated how SDOH (i.e., employment, education, housing, criminal justice involvement, marital status, prior treatment history, health insurance coverage and treatment duration) and SUD severity-related factors (i.e., age of first use, polysubstance use, and presence of a co-occurring psychiatric disorder) influence SUD treatment success and substance use outcomes and whether these relationships differ between men and women. We hypothesized that key SDOH and SUD severity-related factors, reflecting known structural and clinical barriers, would significantly predict poorer treatment outcomes, and that these predictive associations would be stronger in women given their amplified vulnerabilities to these risk factors. MATERIALS & METHODS Data Source and Sample The present analysis included all TEDS-D records from 2018 to 2022. This five-year period rendered a large sample size and allowed for the study of current trends in SUD treatment completion and substance use at discharge. Treatment Outcomes : Two primary outcome variables were analyzed: (1) substance use at discharge (non-abstinent vs. abstinent) and (2) treatment completion (non-completion vs. completion). Substance Use at Discharge was determined based on the primary substance recorded at discharge. Individuals who did not report using any substance at discharge were categorized as abstinent, while those who had a recorded substance use at discharge were categorized as non-abstinent. Episodes with missing substance use data at discharge were excluded. Treatment completion was determined based on an individual’s discharge status. The discharge “reason” variable in the dataset was recoded into a binary outcome variable, where individuals who successfully completed treatment were classified as treatment completers, while those who did not complete treatment for any reason (e.g., dropped out, transferred, administrative discharge) were classified as non-completers. Episodes where the discharge reason was recorded as “death” were excluded from the analysis. Predictor Variables A range of independent variables were included to examine their influence on treatment completion and substance use at discharge. SDOH Variables : Variable selection was guided by the Health People 2030 social SDOH framework, which identifies five key domains influencing health outcomes: economic stability, education access and quality, health care access and quality, neighborhood and built environment and social and community context (Office of Disease Prevention and Health Promotion [ODPHP], 2020). In this study, core SDOH predictors included employment status (employed vs. unemployed), education level (categorized as high school or less vs. some college or more), housing status (housed vs. unhoused), and criminal justice involvement (history of prior arrests vs. none). Marital status (married vs. not married) was included as an indicator of social support, reflecting the social and community context domain. To capture healthcare access and quality, we included prior treatment history (had prior treatment vs. no prior treatment), health insurance type (none vs. public vs. private insurance coverage), and treatment duration (< 30 days vs. 31 + days). SUD Severity-Related Variables Key SUD severity-related predictors included age of first substance use (17 years or younger, 18–29 years, or 30 + years), as well as a polysubstance use score, calculated by summing the substance-specific variables available in the dataset. These variables denote whether a specific substance (e.g. alcohol, cocaine, methamphetamine, etc.) was reported at admission, with each substance coded as present or not. A higher score indicates a greater number of substances used and increased substance use severity. We also included a binary predictor indicating the presence or absence of a co-occurring psychiatric disorder at admission (mental health diagnosis vs. none). Other Covariates : Demographic variables including age (young adults: 18–29 years, middle-aged adults: 30–49 years, older adults: 50 + years), sex (men, women), race (White, Black/African American, American Indian/Alaska Native or Asian/Pacific Islander, and Other), and ethnicity (Hispanic/Latino, Not Hispanic/Latino) were included as covariates. Sample Selection and Data Cleaning To maintain consistency in subgroup analyses, our sample was limited to adults (ages 18 and older) and episodes with missing demographic data (race, sex, or ethnicity) were excluded. Additionally, individuals whose primary substance at admission was listed as 'none' were excluded (11.49%) and the study focused on individuals with reported, current substance use at admission. For all predictor variables, episodes with missing data were excluded using listwise deletion at the model level. The final sample included a total of 7,522,532 adults (36% women) presenting with SUD. Statistical Analysis All variables included in the analysis were categorical. To examine the influence of SDOH and SUD severity-related variables on treatment completion and substance use at discharge, a series of binary logistic regression models were conducted. First, individual binary logistic regression models were run for each SDOH and SUD severity-related predictor individually, while controlling for covariates. Each model included age, race, and ethnicity as covariates to adjust for potential confounding effects. To evaluate whether the relationship between each predictor and the outcome variables differed by sex, main effect and interaction terms (sex × predictor) were included in the models. If a significant sex × predictor interaction was detected (p < 0.05), stratified analyses were conducted by running the same logistic regression models separately for men and women to examine sex-specific effects. Following the individual predictor analyses, sex-stratified multivariate binary logistic regression models were conducted separately for men and women. Each model included all SDOH and SUD predictors, along with covariates. A backward Wald method was applied to systematically remove non-significant variables and identify the strongest model for predicting treatment completion and substance use at discharge. All significant predictors from prior analysis continued to remain significant in the final sex-stratified multivariate logistic regression models for substance use at discharge and treatment non-completion. Thus, we have not included the multivariate models as they did not provide any new information. All analyses were conducted using SPSS (Version 29) and JMP Pro (Version 17.2). Results were reported as odds ratios (OR) with 95% confidence intervals (CI), and statistical significance was set at p < 0.05. Bonferroni corrections for multiple comparisons did not alter the pattern of findings (i.e., all significant findings remained significant). RESULTS Descriptive statistics for all covariates, predictors, and treatment outcome variables are shown in Table 1 , providing an overview of the sample characteristics and variables examined in the study. Table 1 Percentage Distributions for Covariates, Predictors, and Outcome Variables ( N = 7,526,148) Variable Subcategory Percent of Total Demographics Sex Males 64.43% Females 35.57% Age Young Adults 44.47% Middle-Aged Adults 53.93% Older Adults 1.60% Race White 68.32% Black/African American 18.05% AIAN/API 4.39% Other 9.24% Ethnicity Hispanic/Latino 13.34% Not Hispanic/Latino 86.66% Social Determinants of Health Employment Employed 28.48% Unemployed 71.52% Education High School or less 74.02% Some College or more 25.98% Housing Housed 86.98% Unhoused 13.02% Recent Arrests None 94.09% Yes 5.91% Marital Status Married 12.66% Not Married 87.34% Access to Treatment Variables : Prior Treatment Had Treatment 61.32% No Prior Treatment 38.68% Health Insurance Type None 27.95% Private 8.37% Public/Government 63.68% Treatment Duration < 30 days 54.26% 31 + days 45.74% SUD Severity Age at First Use < 17 years 47.51% 18 to 29 years 40.00% 30 + years 12.50% Co-Occurring Disorders No 54.44% Yes 45.56% Polysubstance Use 1 substance 42.79% 2 substances 34.82% 3 substances 22.39% Outcomes Discharge Status Use at Discharge 90.85% Abstinent 9.15% Treatment Completion Yes 42.85% No 57.15% Substance Use at Discharge SDOH. As shown in Table 2 , several SDOH were significantly associated with substance use at discharge. Risk of continued use upon discharge was higher among individuals who were unemployed, had attained some college education or higher, had a recent arrest history, or were entering treatment for the first time. In contrast, having either public or private health insurance coverage, compared to no insurance, was associated with lower risk of substance use at discharge. While these patterns were generally consistent across sexes, some differences in the strength of the associations were observed. Unemployment and recent arrests were linked to increased risk of continued substance use at discharge for both men and women, with effects more pronounced in women. Higher education levels and lack of prior treatment were also associated with increased risk of substance use upon discharge in both sexes but showed stronger effects in men. Health insurance coverage was protective across sexes, with a slightly stronger protective effect in women. Housing status, marital status, and treatment duration were not significantly associated with substance use at discharge in either sex. Table 2 Odds Ratios for Predictors of Substance Use at Discharge , Stratified by Sex Men Women Predictor Level Overall Interaction Significance with Sex OR (95% CI) OR (95% CI) Men vs Women Comparison OR (95% CI); Males = REF Social Determinants of Health Employment Employed < .001 REF REF Unemployed 1.13 (1.12, 1.14) a 1.25 (1.24, 1.27) a 1.08 (1.07, 1.10) a Education High School or less < .001 REF REF Some College or more 1.33 (1.32, 1.34) a 1.22 (1.21, 1.24) a 0.92 (0.90, 0.93) a Housing Housed n.s. Unhoused Recent Arrests None < .001 REF REF Yes 1.23 (1.21, 1.26) a 1.27 (1.25, 1.30) a 1.05 (1.02, 1.08) a Marital Status Married n.s. Not Married Prior Treatment Had Treatment < .001 REF REF No Prior Treatment 1.31 (1.30, 1.32) a 1.22 (1.21, 1.23) a 0.94 (0.93, 0.95) a Health Insurance Type None < .001 REF REF Private 0.21 (0.21, 0.22) a 0.17 (0.16, 0.17) a 0.76 (0.74, 0.78) a Public/Government 0.28 (0.28, 0.28) a 0.25 (0.24, 0.25) a 0.87 (0.85, 0.88) a Treatment Duration < 30 days n.s. 31 + days SUD Severity Age at First Use < 17 years < .001 REF REF 18 to 29 years 0.82 (0.81, 0.83) a 0.94 (0.93, 0.95) a 1.15 (1.13, 1.16) a 30 + years 0.88 (0.87, 0.89) a 1.05 (1.03, 1.07) a 1.15 (1.13, 1.18) a Co-Occurring Psychiatric Disorders No < .001 REF REF Yes 0.96 (0.95, 0.96) a 1.20 (1.18, 1.21) a 1.25 (1.24, 1.27) a Polysubstance Use 1 substance < .001 REF REF 2 substances 1.31 (1.30, 1.33) a 1.44 (1.42, 1.45) a 1.10 (1.08, 1.11) a 3 substances 1.77 (1.75, 1.79) a 2.03 (2.00, 2.06) a 1.16 (1.13, 1.18) a Note: Last column shows ORs for Predictor × Sex interaction (F vs. M; M = REF); a = p .01; n.s. = no significant difference. SUD Severity-Related Predictors. Several clinical severity factors were associated with greater risk of substance use at discharge. Polysubstance use showed a dose-response relationship, with use of two or more substances increasing risk compared to single-substance use. In contrast, late age of first substance use was generally protective. Individuals who began using their primary substance between ages 18–29 or after age 30 were less likely to use substances at discharge than those who started before age 17. Psychiatric comorbidities were also associated with elevated risk for substance use at discharge, though not uniformly. These associations varied by sex, where women showed greater vulnerability related to both polysubstance use and co-occurring psychiatric disorders, while the protective effects of later substance use onset were stronger and more consistent among men. Notably, substance use beginning after age 30 was protective for men but associated with elevated risk in women. Treatment Non-Completion SDOH. As presented in Table 3 , risk of treatment non-completion was higher among individuals who were unemployed, unhoused, unmarried, or entering treatment for the first time. Conversely, having health insurance, whether public or private, was associated with a lower likelihood of dropout. Risk for treatment attrition varied for certain predictors based on sex. Women showed greater risk of not completing treatment associated with unemployment and unstable housing, while men showed greater vulnerability for attrition associated with being unmarried, lacking prior treatment experience, and having a recent arrest. While the sex differences for marital status and prior treatment history were statistically significant, the magnitude of these effects was modest. In contrast, differences by health insurance type were more consistent across sexes. Health insurance coverage reduced dropout risk in both sexes, with public insurance coverage showing a slightly stronger effect among women and private coverage showing modestly stronger effect among men. Education level was not significantly associated with treatment non-completion in either sex. Table 3 Odds Ratios for Predictors of Treatment Non-Completion , Stratified by Sex Men Women Predictor Level Overall Interaction Significance with Sex OR (95% CI) OR (95% CI) Men vs Women Comparison OR (95% CI); Males = REF Social Determinants of Health Employment Employed < .001 REF REF Unemployed 1.53 (1.53, 1.54) a 1.66 (1.65, 1.67) a 1.08 (1.07, 1.09) a Education High School or less n.s. Some College or more Housing Housed < .001 REF REF Unhoused 1.11 (1.11, 1.12) a 1.34 (1.33, 1.36) a 1.21 (1.19, 1.22) a Recent Arrests None < .001 REF REF Yes 1.19 (1.18, 1.20) a 1.01 (1.00, 1.02) b 0.85 (0.84, 0.87) a Marital Status Married .001 REF REF Not Married 1.08 (1.07, 1.08) a 1.06 (1.05, 1.07) a 0.98 (0.97, 0.99) a Prior Treatment Had Treatment < .001 REF REF No Previous Treatment 1.16 (1.16, 1.17) a 1.15 (1.14, 1.15) a 0.99 (0.98, 0.99) a Health Insurance Type None < .001 REF REF Private 0.65 (0.64, 0.65) a 0.67 (0.66, 0.68) a 1.04 (1.02, 1.06) a Public/Government 0.77 (0.77, 0.78) a 0.72 (0.72, 0.73) a 0.93 (0.92, 0.94) a Treatment Duration < 30 days < .001 REF REF 31 + days 1.02 (1.01, 1.02) a 0.96 (0.95, 0.96) a 0.94 (0.94, 0.95) a SUD Severity Age at First Use < 17 years < .001 REF REF 18 to 29 years 1.18 (1.17, 1.18) a 1.24 (1.23, 1.24) a 1.05 (1.04, 1.05) a 30 + years 1.59 (1.58, 1.60) a 1.52 (1.51, 1.53) a 0.96 (0.96, 0.99) a Co-Occurring Psychiatric Disorders No < .001 REF REF Yes 1.47 (1.47, 1.48) a 1.56 (1.55, 1.57) a 1.20 (1.20, 1.21) a Polysubstance Use 1 substance < .001 REF REF 2 substances 1.26 (1.25, 1.27) a 1.29 (1.28, 1.30) a 1.02 (1.01, 1.03) a 3 substances 1.41 (1.40, 1.42) a 1.53 (1.52, 1.54) a 1.08 (1.07, 1.09) a Note: Last column shows ORs for Predictor × Sex interaction (F vs. M; M = REF); a = p .01; n.s. = no significant difference. SUD Severity-Related Predictors. Later onset of substance use, co-occurring psychiatric disorders, and polysubstance use were all associated with increased risk of treatment non-completion. Individuals who initiated substance use at age 30 or older had the highest likelihood of dropout, as did those reporting concurrent mental health diagnoses or using multiple substances at treatment admission. The strength of these associations varied by sex. Women showed greater risk related to psychiatric comorbidities and polysubstance use, while men exhibited greater risk when entering treatment after age 30. All results are reported in Table 3 . DISCUSSION This study examined how SDOH and SUD severity-related factors influence treatment outcomes in publicly funded SUD programs, with a focus on sex differences. Overall, we found that both SDOH and SUD severity indicators were strongly associated with substance use at discharge and treatment non-completion. Social and severity-related factors, such as unemployment, psychiatric comorbidity, and polysubstance use were consistently associated with poorer outcomes, especially for women. In contrast, fewer predictors, such as the lack of prior treatment, were more strongly associated with worse treatment outcomes in men, especially for substance use at discharge. These findings suggest that sex plays an important role in shaping how social and clinical vulnerabilities influence treatment outcomes. SDOH and Treatment Outcomes Economic instability significantly impacted both substance use at discharge and treatment completion, with women more vulnerable to these effects. Unemployment was a consistent predictor of worse treatment outcomes across sexes, but the impact was stronger in women in both treatment outcomes. While employment is generally protective against treatment dropout for both men and women, women may be more vulnerable to the effects of unemployment due to compounded stressors including financial strain and caregiving responsibilities (Ogden, Dichter & Bazzi, 2022 ; Greenfield et al., 2007 ). These stressors may interfere with treatment retention and increase the likelihood of continued use. Similarly, educational attainment was protective against substance use at discharge; however, this also showed sex-differences in associations. Individuals with at least some college education had greater odds of substance use at discharge compared to those with a high school education or less, especially among men. Interestingly, this observation was in an unexpected direction given that higher education levels are typically associated with better health outcomes. However, this pattern may be reflective of heavier substance use among college-aged men, consistent with existing research (Iwamoto et al., 2011 ). Nevertheless, the dataset used did not include direct information on substance use severity, limiting our ability to determine whether this association reflects pre-treatment use patterns. Housing instability was associated with a decreased risk for treatment completion. While housing status did not significantly predict substance use at discharge, it was strongly associated with elevated dropout risk, especially among women. These findings reinforce the importance of housing stability for women to remain active in treatment programs (Kneck et al., 2021 ), especially since unhoused women often face compounding structural and interpersonal barriers to care despite reporting high motivation to complete treatment (Upshur et al., 2018 ). History of recent arrests also impacted treatment outcomes, with specific sex differences emerging. Arrest history predicted continued substance use at discharge in both sexes, though the effect was stronger in women. This pattern aligns with existing literature demonstrating that legal system involvement often co-occurs with trauma, caregiving stress, and family system instability (Scott & Dennis, 2012 ; Bloom et al., 2003 ), factors that women are particularly sensitive to and thus may translate to poorer treatment outcomes in women. Additionally, recent arrests were more strongly associated with treatment dropout among men only. This is consistent with research that there is lower engagement in court-mandated care (Expósito-Álvarez et al., 2023 ). For women, results suggest that while they were more compliant with attending treatment, they were nonetheless more likely to be using substances at discharge. Marital status, used as an indicator of social support was associated with a slightly increased risk of treatment non-completion among unmarried individuals, with a statistically stronger effect in men, though the magnitude of this sex difference was modest. While marital status may not always reflect the presence or quality of social support (e.g. a partner may be emotionally unavailable or unsupportive), it can still serve as a general indicator of access to close relational social support. This may reflect sex differences in the availability and reliance on emotional support, as men are more likely to depend on romantic partners for support than women, who have broader social support networks outside their relationships (Wahring et al., 2024 ). Access to Treatment Individuals entering treatment for the first time had higher odds of both treatment non-completion and substance use at discharge compared to those with prior treatment experience, with both outcomes more pronounced in men. However, the magnitude of the sex difference was small for treatment non-completion, while the effect on substance use at discharge was more substantial. These findings support the evidence that recovery is rarely linear, often requiring multiple episodes of care over time as individuals cycle through periods of substance use, treatment, and re-engagement (Dennis & Scott, 2007 ). Health insurance coverage was a consistent protective factor across both treatment outcomes, though the strength of these associations varied slightly by sex. Compared to individuals without insurance coverage, those with private or public coverage had lower odds of substance use at discharge and were more likely to complete treatment. However, this protective effect was more pronounced in women related to substance use at discharge, while men showed slightly stronger benefits from private coverage in reducing dropout. These patterns may reflect reduced financial burden and continuity of care, as consistent health insurance coverage has shown to improve utilization of substance use, mental health and related services, especially among low-income adults with SUDs (Olfson et al., 2022 ). These findings may reflect differences in treatment quality and consistency of care across the different funding sources, suggesting that access to well-funded care plans play an important role in supporting positive outcomes. Lastly, longer treatment duration was slightly protective against treatment non-completion, with stays of 31 days or more associated with reducing dropout risk in women. This pattern aligns with prior work showing that extended treatment is particularly beneficial in female-specific programs (Davis et al., 2024 ). SUD Severity-Related Predictors of Treatment Outcomes Later onset of substance use was associated with lower odds of substance use at discharge, particularly among men and women who initiated use between ages 18–29. This finding aligns with research showing that earlier initiation is associated with more severe and persistent substance use trajectories (Jordan & Andersen, 2017 ; Poudel & Gautam, 2017 ). In contrast, later age of substance use onset was associated with increased risk of treatment non-completion compared to early onset (< 17 years old), with the strongest effects observed among individuals whose use began at the age of 30 or older, in both men and women. For men, this may reflect entry into treatment in response to external pressures, such as job- or legal-related consequences, rather than intrinsic motivation to change (Weisner et al., 2002 ). For women, life responsibilities, such as employment or family responsibilities, may interfere with their ability to remain in treatment over time (Greenfield et al., 2007 ; Bloom et al., 2003 ). Notably, this pattern may also reflect a broader public health trend of increasing substance use among older women, often in response to stress, isolation, or changing social roles (Patra et al., 2024 ; Stelander et al., 2021 ). Polysubstance use predicted both substance use at discharge and non-completion, especially in women, with outcomes worsening as the number of substances increased. Women who reported using three substances had the highest likelihood of continued use and dropout, consistent with prior findings that polysubstance-using women often present with more complex clinical profiles, including co-occurring psychiatric conditions and poorer physical health compared to men (Rodriguez et al., 2022 ; Moss et al., 2015 ). Co-occurring psychiatric disorders were associated with poorer treatment outcomes, particularly among women. This is highly consistent with prior research showing that women with SUDs are more likely to experience conditions such as depression, anxiety, and posttraumatic stress disorder (Chander & McCaul, 2003 ; Zilberman et al., 2003 ), which can complicate recovery and increase vulnerability to continued use even after treatment ends. Clinical Implications These findings emphasize the importance of tailoring SUD treatment approaches based on both SDOH and clinical severity, while accounting for sex-specific risk patterns. While several predictors, such as unemployment, psychiatric comorbidities and polysubstance use, were significant across sexes, women showed a more consistent pattern of vulnerability associated with poorer treatment outcomes. This suggests that more comprehensive treatment models, that incorporate trauma-informed care, stronger mental health support, and logistical support systems like childcare and transportation, may be especially beneficial for women. Among men, risk patterns varied more across predictors and treatment outcomes, but a history of prior treatment stood out as a consistent predictor associated with both substance use at discharge and treatment dropout. Although the sex difference in drop out related to prior treatment history was modest, this finding emphasizes the need for stronger engagement strategies for men entering treatment for the first time, especially for men entering treatment through external pressures. Programs may also benefit from fostering opportunities for men to build meaningful relationships, given our modest but significant findings related to marital status, and incorporating diversion-based to address criminal-legal system involvement. Designing treatment plans that respond to both real-world barriers and clinical needs, especially in ways that reflect the different challenges men and women face, will improve treatment retention and support sustained recovery. Limitations and Future Directions This study leveraged a large, nationally representative dataset to explore predictors of treatment outcomes in publicly funded SUD programs. While the dataset provided a substantial amount of information of treatment episodes, it was limited in the specificity of the available variables. Important psychosocial variables, such as treatment motivation, trauma history, perceived quality of care, quality of social support, and household responsibilities (e.g., childcare) were not captured, despite their well-established influence on recovery outcomes. Additionally, both substance use at discharge and treatment non-completion outcome variables were recoded using discharge codes rather than long-term behavioral outcomes, limiting insight into sustained recovery. Moreover, because the dataset only includes individuals who had already been discharged, it excludes those still in treatment and may not reflect the full range of treatment participation or continuity. Several predictors were also recoded into broader categorical variables, which may obscure within-group differences. Future research should incorporate more detailed, longitudinal designs, including post-discharge outcomes and stronger psychosocial data, to better understand recovery patterns and treatment engagement across sexes. CONCLUSION Findings from this study highlight the need for sex-informed approaches to SUD treatment that address both clinical severity and structural risk factors. Tailoring treatment approaches to reflect these distinct patterns may improve recovery outcomes. As treatment systems continue to evolve, integrating these insights can help close longstanding gaps in care and better support sustained recovery. Declarations Ethics Approval and Consent to Participate: Not applicable. Consent for Publication: Not applicable. Data Availability: Data is available upon reasonable request. Competing Interests: The authors declare no competing interests. Funding: Support provided by National Institutes of Health T32AA029259 (CLJC); U54AA027989 (SAM). Author Contributions: SAM and CLJC conceptualized the study. CLJC cleaned and analyzed the publicly available SAMHSA dataset, with statistical guidance from SAM. CLJC drafted the manuscript. All authors contributed to manuscript revisions, and SAM supervised the project. References Acevedo A, Panas L, Garnick D, Acevedo-Garcia D, Miles J, Ritter G, Campbell K. Disparities in the Treatment of Substance Use Disorders: Does Where You Live Matter? J Behav Health Serv Res. 2018;45(4):533–49. https://doi.org/10.1007/s11414-018-9586-y . Amaro H, Sanchez M, Bautista T, Cox R. Social vulnerabilities for substance use: Stressors, socially toxic environments, and discrimination and racism. Neuropharmacology. 2021;188:108518. https://doi.org/10.1016/j.neuropharm.2021.108518 . Andersson HW, Mosti MP, Nordfjaern T. Inpatients in substance use treatment with co-occurring psychiatric disorders: a prospective cohort study of characteristics and relapse predictors. BMC Psychiatry. 2023;23(1):152. https://doi.org/10.1186/s12888-023-04632-z . Bhalla IP, Stefanovics EA, Rosenheck RA. Clinical Epidemiology of Single Versus Multiple Substance Use Disorders: Polysubstance Use Disorder. Med Care. 2017;55:S24–32. https://doi.org/10.1097/MLR.0000000000000731 . Bloom B, Owen B, Covington S, Raeder M. Gender-Responsive Strategies: Research, Practice, and Guiding Principles for Women Offenders. Washington, DC: US Department of Justice, National Institute of Corrections; 2003. Centers for Disease Control and Prevention (CDC). (2023). Social Determinants of Health: Know What Affects Health . Retrieved from https://www.cdc.gov/socialdeterminants Chan B, Hoffman KA, Bougatsos C, Grusing S, Chou R, McCarty D. Mobile methadone medication units: A brief history, scoping review and research opportunity. J Subst Abuse Treat. 2021;129:108483. https://doi.org/10.1016/j.jsat.2021.108483 . Chander G, McCaul ME. Co-occurring psychiatric disorders in women with addictions. Obstet Gynecol Clin N Am. 2003;30(3):469–81. https://doi.org/10.1016/s0889-8545(03)00079-2 . Chi FW, Weisner C, Grella CE, Hser YI, Moore C, Mertens J. Does age at first treatment episode make a difference in outcomes over 11 years? J Subst Abuse Treat. 2014;46(4):482–90. https://doi.org/10.1016/j.jsat.2013.12.003 . Coviello DM, Zanis DA, Wesnoski SA, Palman N, Gur A, Lynch KG, McKay JR. Does mandating offenders to treatment improve completion rates? J Subst Abuse Treat. 2013;44(4):417–25. https://doi.org/10.1016/j.jsat.2012.10.003 . Davis DW, Feygin Y, Shipley M, Hall TC, Downs C, Hoskins S, Pasquenza N, Duncan SD, Creel LM. A case report on a women's residential substance use program in a rural and urban setting. Matern Child Health J. 2024;28(11):1870–5. https://doi.org/10.1007/s10995-024-03993-5 . Dennis M, Scott CK. Managing addiction as a chronic condition. Addict Sci Clin Pract. 2007;4(1):45–55. https://doi.org/10.1151/ascp074145 . Expósito-Álvarez C, Santirso FA, Gilchrist G, Gracia E, Lila M. Participants in Court-mandated Intervention Programs for Intimate Partner Violence Perpetrators with Substance Use Problems: A Systematic Review of Specific Risk Factors. Psychosocial intervention. 2023;32(2):89–108. https://doi.org/10.5093/pi2023a7 . Goodwin SR, Moskal D, Marks RM, Clark AE, Squeglia LM, Roche DJO. A Scoping Review of Gender, Sex and Sexuality Differences in Polysubstance Use in Adolescents and Adults. Alcohol Alcohol. 2022;57(3):292–321. https://doi.org/10.1093/alcalc/agac006 . Greenfield SF, Brooks AJ, Gordon SM, Green CA, Kropp F, McHugh RK, Lincoln M, Hien D, Miele GM. Substance abuse treatment entry, retention, and outcome in women: a review of the literature. Drug Alcohol Depend. 2007;86(1):1–21. https://doi.org/10.1016/j.drugalcdep.2006.05.012 . Iwamoto DK, Cheng A, Lee CS, Takamatsu S, Gordon D. Man-ing up and getting drunk: the role of masculine norms, alcohol intoxication and alcohol-related problems among college men. Addict Behav. 2011;36(9):906–11. https://doi.org/10.1016/j.addbeh.2011.04.005 . Jordan CJ, Andersen SL. Sensitive periods of substance abuse: Early risk for the transition to dependence. Dev Cogn Neurosci. 2017;25:29–44. https://doi.org/10.1016/j.dcn.2016.10.004 . Keyes KM, Martins SS, Blanco C, Hasin DS. Telescoping and gender differences in alcohol dependence: new evidence from two national surveys. Am J Psychiatry. 2010;167(8):969–76. https://doi.org/10.1176/appi.ajp.2009.09081161 . Kneck Å, Mattsson E, Salzmann-Erikson M, Klarare A, in collaboration with Women Advisory Board for Inclusion Health. Stripped of dignity - Women in homelessness and their perspectives of healthcare services: A qualitative study. Int J Nurs Stud. 2021;120:103974. https://doi.org/10.1016/j.ijnurstu.2021.103974 . Krawczyk N, Feder KA, Saloner B, Crum RM, Kealhofer M, Mojtabai R. The association of psychiatric comorbidity with treatment completion among clients admitted to substance use treatment programs in a U.S. national sample. Drug Alcohol Depend. 2017;175:157–63. https://doi.org/10.1016/j.drugalcdep.2017.02.006 . Lin C, Cousins SJ, Zhu Y, Clingan SE, Mooney LJ, Kan E, Wu F, Hser YI. A scoping review of social determinants of health's impact on substance use disorders over the life course. J Subst use Addict Treat. 2024;166:209484. https://doi.org/10.1016/j.josat.2024.209484 . McHugh RK, Votaw VR, Sugarman DE, Greenfield SF. Sex and gender differences in substance use disorders. Clin Psychol Rev. 2018;66:12–23. https://doi.org/10.1016/j.cpr.2017.10.012 . Moss HB, Goldstein RB, Chen CM, Yi HY. Patterns of use of other drugs among those with alcohol dependence: Associations with drinking behavior and psychopathology. Addict Behav. 2015;50:192–8. https://doi.org/10.1016/j.addbeh.2015.06.041 . Office of Disease Prevention and Health Promotion. Social determinants of health. U.S. Department of Health and Human Services; 2020. https://health.gov/healthypeople/priority-areas/social-determinants-health . Ogden SN, Dichter ME, Bazzi AR. Intimate partner violence as a predictor of substance use outcomes among women: A systematic review. Addict Behav. 2022;127:107214. https://doi.org/10.1016/j.addbeh.2021.107214 . Olfson M, Mauro C, Wall MM, Choi CJ, Barry CL, Mojtabai R. Healthcare coverage and service access for low-income adults with substance use disorders. J Subst Abuse Treat. 2022;137:108710. https://doi.org/10.1016/j.jsat.2021.108710 . Parlier-Ahmad AB, Radic M, Svikis DS, Martin CE. Short communication: Relationship between social determinants and opioid use disorder treatment outcomes by gender. Drug Alcohol Depend. 2022;232:109337. https://doi.org/10.1016/j.drugalcdep.2022.109337 . Patra S, Patra S, Das R, Patra SS. Rising Trend of Substance Abuse Among Older Adults: A Review Focusing on Screening and Management. Cureus. 2024;16(12):e76659. https://doi.org/10.7759/cureus.76659 . Peacock A, Eastwood B, Jones A, Millar T, Horgan P, Knight J, Randhawa K, White M, Marsden J. Effectiveness of community psychosocial and pharmacological treatments for alcohol use disorder: A national observational cohort study in England. Drug Alcohol Depend. 2018;186:60–7. https://doi.org/10.1016/j.drugalcdep.2018.01.019 . Polcin DL, Korcha R. Social Support Influences on Substance Abuse Outcomes Among Sober Living House Residents with Low and Moderate Psychiatric Severity. J alcohol drug Educ. 2017;61(1):51–70. Poudel A, Gautam S. Age of onset of substance use and psychosocial problems among individuals with substance use disorders. BMC Psychiatry. 2017;17(1):10. https://doi.org/10.1186/s12888-016-1191-0 . Redeł A, Binkowska AA, Obarska K, Marcowski P, Szymczak K, Lewczuk K, Solich K, Banaszak M, Woronowicz B, Nowicka M, Skorko M, Gola M, Bielecki M. Evaluating the effectiveness of a mobile app-based self-guided psychological interventions to reduce relapse in substance use disorder: protocol for a randomized controlled trial. Front Psychiatry. 2024;15:1335105. https://doi.org/10.3389/fpsyt.2024.1335105 . Rodriguez AS, Robinson LD, Kelly PJ, Hudson S. Polysubstance use classes and health outcomes among women attending specialist substance use treatment services. Drug Alcohol Rev. 2022;41(2):488–500. https://doi.org/10.1111/dar.13375 . Scott CK, Dennis ML. The first 90 days following release from jail: findings from the Recovery Management Checkups for Women Offenders (RMCWO) experiment. Drug Alcohol Depend. 2012;125(1–2):110–8. https://doi.org/10.1016/j.drugalcdep.2012.03.025 . Shaffer PM, Gaba A, Sprinckmoller SP, Starratt EL, Smelson DA. (2019). Treatment needs and gender differences among clients entering a rural drug treatment court with a co-occurring disorder. Drug court review , 26 . Stelander LT, Høye A, Bramness JG, Selbæk G, Lunde LH, Wynn R, Grønli OK. (2021). The changing alcohol drinking patterns among older adults show that women are closing the gender gap in more frequent drinking: the Tromsø study, 1994–2016. Substance abuse treatment, prevention, and policy , 16 (1), 45. https://doi.org/10.1186/s13011-021-00376-9 Substance Abuse and Mental Health Services Administration (SAMHSA). (2024). Key substance use and mental health indicators in the united states: Results from the 2023 National Survey on Drug Use and Health [Report]. Towers EB, Williams IL, Qillawala EI, Rissman EF, Lynch WJ. Sex/Gender Differences in the Time-Course for the Development of Substance Use Disorder: A Focus on the Telescoping Effect. Pharmacol Rev. 2023;75(2):217–49. https://doi.org/10.1124/pharmrev.121.000361 . Upshur CC, Jenkins D, Weinreb L, Gelberg L, Orvek EA. Homeless women's service use, barriers, and motivation for participating in substance use treatment. Am J Drug Alcohol Abus. 2018;44(2):252–62. https://doi.org/10.1080/00952990.2017.1357183 . Wahring IV, Simpson JA, Van Lange PAM. Romantic Relationships Matter More to Men than to Women. Behav Brain Sci. 2024;1–64. https://doi.org/10.1017/S0140525X24001365 . Advance online publication. Weisner C, Matzger H, Tam T, Schmidt L. Who goes to alcohol and drug treatment? Understanding utilization within the context of insurance. J Stud Alcohol. 2002;63(6):673–82. https://doi.org/10.15288/jsa.2002.63.673 . Zilberman ML, Tavares H, Blume SB, el-Guebaly N. Substance use disorders: sex differences and psychiatric comorbidities. Can J Psychiatry. 2003;48(1):5–13. https://doi.org/10.1177/070674370304800103 . Additional Declarations No competing interests reported. Supplementary Files JimenezChavezManuscriptAdditionalFiles1.docx Cite Share Download PDF Status: Published Journal Publication published 22 Jul, 2025 Read the published version in Biology of Sex Differences → Version 1 posted Editorial decision: Revision requested 12 Jun, 2025 Reviews received at journal 26 May, 2025 Reviewers agreed at journal 08 May, 2025 Reviewers invited by journal 28 Apr, 2025 Editor assigned by journal 15 Apr, 2025 Submission checks completed at journal 15 Apr, 2025 First submitted to journal 10 Apr, 2025 You are reading this latest preprint version Research Square lets you share your work early, gain feedback from the community, and start making changes to your manuscript prior to peer review in a journal. As a division of Research Square Company, we’re committed to making research communication faster, fairer, and more useful. We do this by developing innovative software and high quality services for the global research community. Our growing team is made up of researchers and industry professionals working together to solve the most critical problems facing scientific publishing. Also discoverable on Platform About Our Team In Review Editorial Policies Advisory Board Help Center Resources Author Services Accessibility API Access RSS feed Manage Cookie Preferences © Research Square 2026 | ISSN 2693-5015 (online) Privacy Policy Terms of Service Do Not Sell My Personal Information {"props":{"pageProps":{"initialData":{"identity":"rs-6422698","acceptedTermsAndConditions":true,"allowDirectSubmit":false,"archivedVersions":[],"articleType":"Research Article","associatedPublications":[],"authors":[{"id":449856152,"identity":"a56e920f-a917-4d47-a899-eb1ee4558f2a","order_by":0,"name":"C. Leonardo Jimenez Chavez","email":"data:image/png;base64,iVBORw0KGgoAAAANSUhEUgAAAZAAAAAyAQMAAABI0h/eAAAABlBMVEX///8AAABVwtN+AAAACXBIWXMAAA7EAAAOxAGVKw4bAAABH0lEQVRIiWNgGAWjYBACPhAhYQDhMINJ9gYGhgcgxgHsWtgwtfAAlSYQ0gIDEC0SCQS0sDcfYLAo2CZnzt7+8HNBzWE5+ZlvDD8kVDDI8d1IwK6F51gC0GG3jS17DiRLzzh22Jhxdo6xRMIZBmNJXFokcgxAWhI33Eg4xszDlpbYLJ1jIJHYxgASwa5F/g1YS/2G+w/bmHn+pdW3SZ4x/pH4j6EepxYJHrCWBIMbzGzMvG02CTwSPGYSiQ0MQBFcfklLOADUYrjhTBqzNG+fjeEMnrQyi4RjEoYzzzzAqoWf/fDBxxJ/bssbHD/+8DPPNwl5+fbDm298qLGR5zuO3RYQOCyByucAxawEVqUwwPgBlc+O3UGjYBSMglEwYgEAPwpa28F3AQkAAAAASUVORK5CYII=","orcid":"","institution":"Yale School of Medicine","correspondingAuthor":true,"prefix":"","firstName":"C.","middleName":"Leonardo Jimenez","lastName":"Chavez","suffix":""},{"id":449856153,"identity":"4987e9eb-80af-449e-b8af-9306af02081f","order_by":1,"name":"MacKenzie R. Peltier","email":"","orcid":"","institution":"Yale School of Medicine","correspondingAuthor":false,"prefix":"","firstName":"MacKenzie","middleName":"R.","lastName":"Peltier","suffix":""},{"id":449856154,"identity":"32446107-5b3e-404a-9df8-fe03d8b255fb","order_by":2,"name":"Sherry A. McKee","email":"","orcid":"","institution":"Yale School of Medicine","correspondingAuthor":false,"prefix":"","firstName":"Sherry","middleName":"A.","lastName":"McKee","suffix":""}],"badges":[],"createdAt":"2025-04-10 18:53:18","currentVersionCode":1,"declarations":"","doi":"10.21203/rs.3.rs-6422698/v1","doiUrl":"https://doi.org/10.21203/rs.3.rs-6422698/v1","draftVersion":[],"editorialEvents":[{"content":"https://doi.org/10.1186/s13293-025-00734-3","type":"published","date":"2025-07-22T15:57:54+00:00"}],"editorialNote":"","failedWorkflow":false,"files":[{"id":87756727,"identity":"a65e7c46-231d-4694-b7c9-41722d572d93","added_by":"auto","created_at":"2025-07-28 16:08:20","extension":"pdf","order_by":0,"title":"","display":"","copyAsset":false,"role":"manuscript-pdf","size":1271055,"visible":true,"origin":"","legend":"","description":"","filename":"manuscript.pdf","url":"https://assets-eu.researchsquare.com/files/rs-6422698/v1/40e77999-7fea-4184-a8fc-1c9558fb9df5.pdf"},{"id":81693172,"identity":"626becea-670d-468f-9451-b38940531c95","added_by":"auto","created_at":"2025-04-30 11:46:48","extension":"docx","order_by":2,"title":"","display":"","copyAsset":false,"role":"supplement","size":34144,"visible":true,"origin":"","legend":"","description":"","filename":"JimenezChavezManuscriptAdditionalFiles1.docx","url":"https://assets-eu.researchsquare.com/files/rs-6422698/v1/4f3bf721de6163f9691ff2e6.docx"}],"financialInterests":"No competing interests reported.","formattedTitle":"Sex Differences in the Impact of Social Determinants of Health on Substance Use Disorder Treatment Outcomes","fulltext":[{"header":"PLAIN ENGLISH SUMMARY ","content":"\u003cp\u003eSubstance use treatment is not a one-size-fits-all process. Recovery is shaped by both structural challenges, such as housing instability or limited access to care, and the clinical severity of substance use. These factors influence whether someone completes treatment and stays abstinent, and they often affect men and women in different ways. In this study, we examined over 7 million episodes of publicly funded substance use treatment programs from across the United States. We looked at how social determinants of health (e.g. employment status, education, housing, access to treatment) and clinical factors (e.g. age of substance use onset, psychiatric comorbidities and polysubstance use), were associated with two key outcomes: whether a person completed treatment and whether they reported using substance at the end of care. We found that women often faced greater challenges, especially regarding unstable housing, co-occurring mental health conditions and using more than one type of substance. For men, being new to treatment was a strong predictor of poorer treatment success. These findings demonstrate the need for treatment programs to offer support that meets men and women where they are, considering the different barriers and challenges each group may face along the path to sustained recovery.\u003c/p\u003e"},{"header":"HIGHLIGHTS","content":"\u003cul\u003e\n \u003cli\u003eWe examined social determinants of health (SDOH) and substance use disorder (SUD) severity-related predictors of substance use and treatment completion in a national sample of over 7 million adults.\u003c/li\u003e\n \u003cli\u003eWomen demonstrated more consistent vulnerability across predictors, including unemployment, co-occurring psychiatric disorders, and polysubstance use.\u003c/li\u003e\n \u003cli\u003eFor men, lack of prior treatment for SUD was the most consistent predictor for substance use at discharge and treatment dropout.\u0026nbsp;\u003c/li\u003e\n \u003cli\u003eHousing instability, access to healthcare, and financial barriers showed sex-specific effects, with women generally experiencing great risk of unsuccessful treatment.\u0026nbsp;\u003c/li\u003e\n \u003cli\u003eFindings highlight the importance of improving SUD care to address sex-specific risks and structural barriers, especially in publicly funded systems.\u0026nbsp;\u003c/li\u003e\n\u003c/ul\u003e"},{"header":"BACKGROUND","content":"\u003cp\u003eSubstance Use Disorders (SUDs) are a major global public health concern, contributing to significant health and social burdens that affect millions of individuals, their families and their communities. In the United States, estimates from the Substance Abuse and Mental Health Services Administration (SAMHSA) approximate that nearly 18% of the population had an SUD diagnosis in 2023 (SAMHSA, 2024). While treatment improves SUD outcomes, 76% of individuals with SUD did not receive treatment (SAMHSA, 2024). There are numerous barriers to treatment which are influenced by both individual and structural factors, including social determinants of health (SDOH).\u003c/p\u003e \u003cp\u003eSDOH are nonmedical conditions in which people are born, grow, live, work, worship and age that influence a wide range of health and quality-of-life outcomes and risks (Centers for Disease Control and Prevention [CDC], 2023). These factors include employment, education, housing stability, healthcare access, and criminal justice involvement. Studies have demonstrated improved SUD treatment outcomes, including increased retention and reduced substance use, when interventions reduce social stressors and provide recovery support (Amaro et al., \u003cspan citationid=\"CR2\" class=\"CitationRef\"\u003e2021\u003c/span\u003e; Polcin \u0026amp; Korcha, \u003cspan citationid=\"CR30\" class=\"CitationRef\"\u003e2017\u003c/span\u003e). Employment status and social support, for example, are strong predictors of better retention in treatment and long-term abstinence (Lin et al., \u003cspan citationid=\"CR21\" class=\"CitationRef\"\u003e2024\u003c/span\u003e). Conversely, individuals who face unemployment, homelessness, or social isolation exhibit a greater risk of non-abstinence (Lin et al., \u003cspan citationid=\"CR21\" class=\"CitationRef\"\u003e2024\u003c/span\u003e). Involvement with the criminal justice system is also associated with worse treatment outcomes, disrupting treatment continuity and disproportionately overwhelming marginalized groups (Peacock et al., \u003cspan citationid=\"CR29\" class=\"CitationRef\"\u003e2018\u003c/span\u003e). The influence of SDOH is particularly evident in publicly funded SUD treatment programs, which often serve the most socioeconomically disadvantaged populations. Individuals in these programs frequently face financial instability, lack of reliable transportation, and limited healthcare access, all factors that hinder treatment retention (Acevedo et al., \u003cspan citationid=\"CR1\" class=\"CitationRef\"\u003e2018\u003c/span\u003e). Efforts to address these social challenges have demonstrated promise in improving engagement in treatment programs and reducing post-treatment drug use (Redeł et al., \u003cspan citationid=\"CR32\" class=\"CitationRef\"\u003e2024\u003c/span\u003e; Chan et al., \u003cspan citationid=\"CR7\" class=\"CitationRef\"\u003e2021\u003c/span\u003e).\u003c/p\u003e \u003cp\u003eSex differences further influence how SDOH play a role in SUD treatment outcomes. Women often face compounding structural and social barriers, including childcare responsibilities, financial dependence, intimate partner violence and stigma, that all impact women\u0026rsquo;s ability to remain engaged in treatment (Ogden, Dichter \u0026amp; Bazzi, \u003cspan citationid=\"CR25\" class=\"CitationRef\"\u003e2022\u003c/span\u003e; McHugh et al., \u003cspan citationid=\"CR22\" class=\"CitationRef\"\u003e2018\u003c/span\u003e; Greenfield et al., \u003cspan citationid=\"CR15\" class=\"CitationRef\"\u003e2007\u003c/span\u003e). These challenges not only impede treatment continuity but can also interfere with the overall progress to abstinence. Conversely, men are more likely to be involved in the legal system and have higher rates of polysubstance use, factors that shape both access to and outcomes of treatment (Goodwin et al., \u003cspan citationid=\"CR14\" class=\"CitationRef\"\u003e2022\u003c/span\u003e; Shaffer et al., \u003cspan citationid=\"CR35\" class=\"CitationRef\"\u003e2019\u003c/span\u003e). Additionally, employment and economic stability play a larger role in treatment retention for men, as job loss or financial instability is a consistent reason for treatment discontinuity (Parlier-Ahmad et al., \u003cspan citationid=\"CR27\" class=\"CitationRef\"\u003e2022\u003c/span\u003e). Despite these well-documented sex differences, research examining the interaction between SDOH and sex in shaping treatment trajectories remains limited.\u003c/p\u003e \u003cp\u003eIn addition to SDOH, substance use severity characteristics also significantly impact treatment outcomes. Variables including age at first use, psychiatric comorbidities and polysubstance use, serve as important predictors of treatment success. An earlier age of first use is associated with increased SUD severity and poorer treatment outcomes (Chi et al., \u003cspan citationid=\"CR9\" class=\"CitationRef\"\u003e2014\u003c/span\u003e). Psychiatric comorbidities further complicate treatment, as individuals with existing dual diagnoses are reported to have a greater likelihood of continued use and treatment non-completion (Krawczyk et al., \u003cspan citationid=\"CR20\" class=\"CitationRef\"\u003e2017\u003c/span\u003e), with women in particular showing higher rates of co-occurring conditions, which further complicate treatment adherence and delay recovery (McHugh et al., \u003cspan citationid=\"CR22\" class=\"CitationRef\"\u003e2018\u003c/span\u003e). Polysubstance use also presents additional treatment challenges, often requiring more robust and long-term interventions (Bhalla et al., \u003cspan citationid=\"CR4\" class=\"CitationRef\"\u003e2017\u003c/span\u003e). While these severity-related factors play a role in influencing treatment outcomes, their interplay with SDOH and interaction with sex remains unclear, thus highlighting the need for a large-scale, data-driven approach to investigate the influence of both SDOH and SUD severity-related factors of treatment outcomes across sexes.\u003c/p\u003e \u003cp\u003eTo address this gap in the literature, the present study uses data from the national Treatment Episode Data Set \u0026ndash; Discharges (TEDS-D), a dataset of annual SUD treatment discharges reported by SAMHSA. TEDS-D provides extensive information on patient demographics, social and economic indicators, substance use history, medical and treatment history and discharge status from individuals discharged from publicly funded SUD treatment programs across the United States. Using this comprehensive dataset, we investigated how SDOH (i.e., employment, education, housing, criminal justice involvement, marital status, prior treatment history, health insurance coverage and treatment duration) and SUD severity-related factors (i.e., age of first use, polysubstance use, and presence of a co-occurring psychiatric disorder) influence SUD treatment success and substance use outcomes and whether these relationships differ between men and women. We hypothesized that key SDOH and SUD severity-related factors, reflecting known structural and clinical barriers, would significantly predict poorer treatment outcomes, and that these predictive associations would be stronger in women given their amplified vulnerabilities to these risk factors.\u003c/p\u003e"},{"header":"MATERIALS \u0026 METHODS","content":"\u003cp\u003e \u003cstrong\u003eData Source and Sample\u003c/strong\u003e \u003cp\u003eThe present analysis included all TEDS-D records from 2018 to 2022. This five-year period rendered a large sample size and allowed for the study of current trends in SUD treatment completion and substance use at discharge.\u003c/p\u003e \u003c/p\u003e \u003cp\u003e \u003cb\u003eTreatment Outcomes\u003c/b\u003e: Two primary outcome variables were analyzed: (1) substance use at discharge (non-abstinent vs. abstinent) and (2) treatment completion (non-completion vs. completion).\u003c/p\u003e \u003cp\u003e \u003cem\u003eSubstance Use at Discharge\u003c/em\u003e was determined based on the primary substance recorded at discharge. Individuals who did not report using any substance at discharge were categorized as abstinent, while those who had a recorded substance use at discharge were categorized as non-abstinent. Episodes with missing substance use data at discharge were excluded.\u003c/p\u003e \u003cp\u003e \u003cem\u003eTreatment completion\u003c/em\u003e was determined based on an individual\u0026rsquo;s discharge status. The discharge \u0026ldquo;reason\u0026rdquo; variable in the dataset was recoded into a binary outcome variable, where individuals who successfully completed treatment were classified as treatment completers, while those who did not complete treatment for any reason (e.g., dropped out, transferred, administrative discharge) were classified as non-completers. Episodes where the discharge reason was recorded as \u0026ldquo;death\u0026rdquo; were excluded from the analysis.\u003c/p\u003e \u003cp\u003e \u003cstrong\u003ePredictor Variables\u003c/strong\u003e \u003cp\u003eA range of independent variables were included to examine their influence on treatment completion and substance use at discharge.\u003c/p\u003e \u003c/p\u003e \u003cp\u003e \u003cem\u003eSDOH Variables\u003c/em\u003e: Variable selection was guided by the Health People 2030 social SDOH framework, which identifies five key domains influencing health outcomes: economic stability, education access and quality, health care access and quality, neighborhood and built environment and social and community context (Office of Disease Prevention and Health Promotion [ODPHP], 2020). In this study, core SDOH predictors included employment status (employed vs. unemployed), education level (categorized as high school or less vs. some college or more), housing status (housed vs. unhoused), and criminal justice involvement (history of prior arrests vs. none). Marital status (married vs. not married) was included as an indicator of social support, reflecting the social and community context domain. To capture healthcare access and quality, we included prior treatment history (had prior treatment vs. no prior treatment), health insurance type (none vs. public vs. private insurance coverage), and treatment duration (\u0026lt;\u0026thinsp;30 days vs. 31\u0026thinsp;+\u0026thinsp;days).\u003c/p\u003e \u003cp\u003e \u003cstrong\u003eSUD Severity-Related Variables\u003c/strong\u003e \u003cp\u003eKey SUD severity-related predictors included age of first substance use (17 years or younger, 18\u0026ndash;29 years, or 30\u0026thinsp;+\u0026thinsp;years), as well as a polysubstance use score, calculated by summing the substance-specific variables available in the dataset. These variables denote whether a specific substance (e.g. alcohol, cocaine, methamphetamine, etc.) was reported at admission, with each substance coded as present or not. A higher score indicates a greater number of substances used and increased substance use severity. We also included a binary predictor indicating the presence or absence of a co-occurring psychiatric disorder at admission (mental health diagnosis vs. none).\u003c/p\u003e \u003c/p\u003e \u003cp\u003e \u003cem\u003eOther Covariates\u003c/em\u003e: Demographic variables including age (young adults: 18\u0026ndash;29 years, middle-aged adults: 30\u0026ndash;49 years, older adults: 50\u0026thinsp;+\u0026thinsp;years), sex (men, women), race (White, Black/African American, American Indian/Alaska Native or Asian/Pacific Islander, and Other), and ethnicity (Hispanic/Latino, Not Hispanic/Latino) were included as covariates.\u003c/p\u003e \u003cp\u003e \u003cstrong\u003eSample Selection and Data Cleaning\u003c/strong\u003e \u003cp\u003eTo maintain consistency in subgroup analyses, our sample was limited to adults (ages 18 and older) and episodes with missing demographic data (race, sex, or ethnicity) were excluded. Additionally, individuals whose primary substance at admission was listed as 'none' were excluded (11.49%) and the study focused on individuals with reported, current substance use at admission. For all predictor variables, episodes with missing data were excluded using listwise deletion at the model level. The final sample included a total of 7,522,532 adults (36% women) presenting with SUD.\u003c/p\u003e \u003c/p\u003e \u003cp\u003e \u003cstrong\u003eStatistical Analysis\u003c/strong\u003e \u003cp\u003eAll variables included in the analysis were categorical. To examine the influence of SDOH and SUD severity-related variables on treatment completion and substance use at discharge, a series of binary logistic regression models were conducted. First, individual binary logistic regression models were run for each SDOH and SUD severity-related predictor individually, while controlling for covariates. Each model included age, race, and ethnicity as covariates to adjust for potential confounding effects. To evaluate whether the relationship between each predictor and the outcome variables differed by sex, main effect and interaction terms (sex \u0026times; predictor) were included in the models. If a significant sex \u0026times; predictor interaction was detected (p\u0026thinsp;\u0026lt;\u0026thinsp;0.05), stratified analyses were conducted by running the same logistic regression models separately for men and women to examine sex-specific effects. Following the individual predictor analyses, sex-stratified multivariate binary logistic regression models were conducted separately for men and women. Each model included all SDOH and SUD predictors, along with covariates. A backward Wald method was applied to systematically remove non-significant variables and identify the strongest model for predicting treatment completion and substance use at discharge. All significant predictors from prior analysis continued to remain significant in the final sex-stratified multivariate logistic regression models for substance use at discharge and treatment non-completion. Thus, we have not included the multivariate models as they did not provide any new information. All analyses were conducted using SPSS (Version 29) and JMP Pro (Version 17.2). Results were reported as odds ratios (OR) with 95% confidence intervals (CI), and statistical significance was set at p\u0026thinsp;\u0026lt;\u0026thinsp;0.05. Bonferroni corrections for multiple comparisons did not alter the pattern of findings (i.e., all significant findings remained significant).\u003c/p\u003e \u003c/p\u003e"},{"header":"RESULTS","content":"\u003cp\u003eDescriptive statistics for all covariates, predictors, and treatment outcome variables are shown in Table\u0026nbsp;\u003cspan refid=\"Tab1\" class=\"InternalRef\"\u003e1\u003c/span\u003e, providing an overview of the sample characteristics and variables examined in the study.\u003c/p\u003e \u003cp\u003e \u003cdiv class=\"gridtable\"\u003e\u003ctable float=\"Yes\" id=\"Tab1\" border=\"1\"\u003e \u003ccaption language=\"En\"\u003e \u003cdiv class=\"CaptionNumber\"\u003eTable 1\u003c/div\u003e \u003cdiv class=\"CaptionContent\"\u003e \u003cp\u003ePercentage Distributions for Covariates, Predictors, and Outcome Variables (\u003cem\u003eN\u003c/em\u003e\u0026thinsp;=\u0026thinsp;7,526,148)\u003c/p\u003e \u003c/div\u003e \u003c/caption\u003e \u003ccolgroup cols=\"5\"\u003e \u003cdiv align=\"left\" class=\"colspec\" colname=\"c1\" colnum=\"1\"\u003e\u003c/div\u003e \u003cdiv align=\"left\" class=\"colspec\" colname=\"c2\" colnum=\"2\"\u003e\u003c/div\u003e \u003cdiv align=\"left\" class=\"colspec\" colname=\"c3\" colnum=\"3\"\u003e\u003c/div\u003e \u003cdiv align=\"left\" class=\"colspec\" colname=\"c4\" colnum=\"4\"\u003e\u003c/div\u003e \u003cdiv align=\"left\" class=\"colspec\" colname=\"c5\" colnum=\"5\"\u003e\u003c/div\u003e \u003cthead\u003e \u003ctr\u003e \u003cth align=\"left\" colname=\"c1\"\u003e\u0026nbsp;\u003c/th\u003e \u003cth align=\"left\" colname=\"c2\"\u003e \u003cp\u003e Variable\u003c/p\u003e \u003c/th\u003e \u003cth align=\"left\" colname=\"c3\"\u003e \u003cp\u003eSubcategory\u003c/p\u003e \u003c/th\u003e \u003cth align=\"left\" colspan=\"2\" nameend=\"c5\" namest=\"c4\"\u003e \u003cp\u003ePercent of Total\u003c/p\u003e \u003c/th\u003e \u003c/tr\u003e \u003c/thead\u003e \u003ctbody\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c1\" morerows=\"10\" rowspan=\"11\"\u003e \u003cp\u003e\u003cb\u003eDemographics\u003c/b\u003e\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c2\" morerows=\"1\" rowspan=\"2\"\u003e \u003cp\u003eSex\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c3\"\u003e \u003cp\u003eMales\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c4\"\u003e \u003cp\u003e64.43%\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colspan=\"1\" nameend=\"c5\" namest=\"c5\"\u003e\u0026nbsp;\u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c3\"\u003e \u003cp\u003eFemales\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c4\"\u003e \u003cp\u003e35.57%\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colspan=\"1\" nameend=\"c5\" namest=\"c5\"\u003e\u0026nbsp;\u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c2\" morerows=\"2\" rowspan=\"3\"\u003e \u003cp\u003eAge\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c3\"\u003e \u003cp\u003eYoung Adults\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c4\"\u003e \u003cp\u003e44.47%\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colspan=\"1\" nameend=\"c5\" namest=\"c5\"\u003e\u0026nbsp;\u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c3\"\u003e \u003cp\u003eMiddle-Aged Adults\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c4\"\u003e \u003cp\u003e53.93%\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colspan=\"1\" nameend=\"c5\" namest=\"c5\"\u003e\u0026nbsp;\u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c3\"\u003e \u003cp\u003eOlder Adults\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c4\"\u003e \u003cp\u003e1.60%\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colspan=\"1\" nameend=\"c5\" namest=\"c5\"\u003e\u0026nbsp;\u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c2\" morerows=\"3\" rowspan=\"4\"\u003e \u003cp\u003eRace\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c3\"\u003e \u003cp\u003eWhite\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c4\"\u003e \u003cp\u003e68.32%\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colspan=\"1\" nameend=\"c5\" namest=\"c5\"\u003e\u0026nbsp;\u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c3\"\u003e \u003cp\u003eBlack/African American\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c4\"\u003e \u003cp\u003e18.05%\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colspan=\"1\" nameend=\"c5\" namest=\"c5\"\u003e\u0026nbsp;\u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c3\"\u003e \u003cp\u003eAIAN/API\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c4\"\u003e \u003cp\u003e4.39%\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colspan=\"1\" nameend=\"c5\" namest=\"c5\"\u003e\u0026nbsp;\u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c3\"\u003e \u003cp\u003eOther\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c4\"\u003e \u003cp\u003e9.24%\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colspan=\"1\" nameend=\"c5\" namest=\"c5\"\u003e\u0026nbsp;\u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c2\" morerows=\"1\" rowspan=\"2\"\u003e \u003cp\u003eEthnicity\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c3\"\u003e \u003cp\u003eHispanic/Latino\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c4\"\u003e \u003cp\u003e13.34%\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colspan=\"1\" nameend=\"c5\" namest=\"c5\"\u003e\u0026nbsp;\u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c3\"\u003e \u003cp\u003eNot Hispanic/Latino\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c4\"\u003e \u003cp\u003e86.66%\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colspan=\"1\" nameend=\"c5\" namest=\"c5\"\u003e\u0026nbsp;\u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c1\" morerows=\"17\" rowspan=\"18\"\u003e \u003cp\u003e\u003cb\u003eSocial Determinants of Health\u003c/b\u003e\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c2\" morerows=\"1\" rowspan=\"2\"\u003e \u003cp\u003eEmployment\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c3\"\u003e \u003cp\u003eEmployed\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c4\"\u003e \u003cp\u003e28.48%\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colspan=\"1\" nameend=\"c5\" namest=\"c5\"\u003e\u0026nbsp;\u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c3\"\u003e \u003cp\u003eUnemployed\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c4\"\u003e \u003cp\u003e71.52%\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colspan=\"1\" nameend=\"c5\" namest=\"c5\"\u003e\u0026nbsp;\u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c2\" morerows=\"1\" rowspan=\"2\"\u003e \u003cp\u003eEducation\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c3\"\u003e \u003cp\u003eHigh School or less\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c4\"\u003e \u003cp\u003e74.02%\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colspan=\"1\" nameend=\"c5\" namest=\"c5\"\u003e\u0026nbsp;\u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c3\"\u003e \u003cp\u003eSome College or more\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c4\"\u003e \u003cp\u003e25.98%\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colspan=\"1\" nameend=\"c5\" namest=\"c5\"\u003e\u0026nbsp;\u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c2\" morerows=\"1\" rowspan=\"2\"\u003e \u003cp\u003eHousing\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c3\"\u003e \u003cp\u003eHoused\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c4\"\u003e \u003cp\u003e86.98%\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colspan=\"1\" nameend=\"c5\" namest=\"c5\"\u003e\u0026nbsp;\u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c3\"\u003e \u003cp\u003eUnhoused\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c4\"\u003e \u003cp\u003e13.02%\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colspan=\"1\" nameend=\"c5\" namest=\"c5\"\u003e\u0026nbsp;\u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c2\" morerows=\"1\" rowspan=\"2\"\u003e \u003cp\u003eRecent Arrests\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c3\"\u003e \u003cp\u003eNone\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c4\"\u003e \u003cp\u003e94.09%\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colspan=\"1\" nameend=\"c5\" namest=\"c5\"\u003e\u0026nbsp;\u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c3\"\u003e \u003cp\u003eYes\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c4\"\u003e \u003cp\u003e5.91%\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colspan=\"1\" nameend=\"c5\" namest=\"c5\"\u003e\u0026nbsp;\u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c2\" morerows=\"1\" rowspan=\"2\"\u003e \u003cp\u003eMarital Status\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c3\"\u003e \u003cp\u003eMarried\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c4\"\u003e \u003cp\u003e12.66%\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colspan=\"1\" nameend=\"c5\" namest=\"c5\"\u003e\u0026nbsp;\u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c3\"\u003e \u003cp\u003eNot Married\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c4\"\u003e \u003cp\u003e87.34%\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colspan=\"1\" nameend=\"c5\" namest=\"c5\"\u003e\u0026nbsp;\u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colspan=\"3\" nameend=\"c4\" namest=\"c2\"\u003e \u003cp\u003e\u003cem\u003eAccess to Treatment Variables\u003c/em\u003e:\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colspan=\"1\" nameend=\"c5\" namest=\"c5\"\u003e\u0026nbsp;\u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c2\" morerows=\"1\" rowspan=\"2\"\u003e \u003cp\u003ePrior Treatment\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c3\"\u003e \u003cp\u003eHad Treatment\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c4\"\u003e \u003cp\u003e61.32%\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colspan=\"1\" nameend=\"c5\" namest=\"c5\"\u003e\u0026nbsp;\u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c3\"\u003e \u003cp\u003eNo Prior Treatment\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c4\"\u003e \u003cp\u003e38.68%\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colspan=\"1\" nameend=\"c5\" namest=\"c5\"\u003e\u0026nbsp;\u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c2\" morerows=\"2\" rowspan=\"3\"\u003e \u003cp\u003eHealth Insurance Type\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c3\"\u003e \u003cp\u003eNone\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c4\"\u003e \u003cp\u003e27.95%\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colspan=\"1\" nameend=\"c5\" namest=\"c5\"\u003e\u0026nbsp;\u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c3\"\u003e \u003cp\u003ePrivate\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c4\"\u003e \u003cp\u003e8.37%\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colspan=\"1\" nameend=\"c5\" namest=\"c5\"\u003e\u0026nbsp;\u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c3\"\u003e \u003cp\u003ePublic/Government\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c4\"\u003e \u003cp\u003e63.68%\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colspan=\"1\" nameend=\"c5\" namest=\"c5\"\u003e\u0026nbsp;\u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c2\" morerows=\"1\" rowspan=\"2\"\u003e \u003cp\u003eTreatment Duration\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c3\"\u003e \u003cp\u003e\u0026lt;\u0026thinsp;30 days\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c4\"\u003e \u003cp\u003e54.26%\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colspan=\"1\" nameend=\"c5\" namest=\"c5\"\u003e\u0026nbsp;\u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c3\"\u003e \u003cp\u003e31\u0026thinsp;+\u0026thinsp;days\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c4\"\u003e \u003cp\u003e45.74%\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colspan=\"1\" nameend=\"c5\" namest=\"c5\"\u003e\u0026nbsp;\u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c1\" morerows=\"7\" rowspan=\"8\"\u003e \u003cp\u003e\u003cb\u003eSUD Severity\u003c/b\u003e\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c2\" morerows=\"2\" rowspan=\"3\"\u003e \u003cp\u003eAge at First Use\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c3\"\u003e \u003cp\u003e\u0026lt;\u0026thinsp;17 years\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c4\"\u003e \u003cp\u003e47.51%\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colspan=\"1\" nameend=\"c5\" namest=\"c5\"\u003e\u0026nbsp;\u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c3\"\u003e \u003cp\u003e18 to 29 years\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c4\"\u003e \u003cp\u003e40.00%\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colspan=\"1\" nameend=\"c5\" namest=\"c5\"\u003e\u0026nbsp;\u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c3\"\u003e \u003cp\u003e30\u0026thinsp;+\u0026thinsp;years\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c4\"\u003e \u003cp\u003e12.50%\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colspan=\"1\" nameend=\"c5\" namest=\"c5\"\u003e\u0026nbsp;\u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c2\" morerows=\"1\" rowspan=\"2\"\u003e \u003cp\u003eCo-Occurring Disorders\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c3\"\u003e \u003cp\u003eNo\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c4\"\u003e \u003cp\u003e54.44%\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colspan=\"1\" nameend=\"c5\" namest=\"c5\"\u003e\u0026nbsp;\u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c3\"\u003e \u003cp\u003eYes\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c4\"\u003e \u003cp\u003e45.56%\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colspan=\"1\" nameend=\"c5\" namest=\"c5\"\u003e\u0026nbsp;\u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c2\" morerows=\"2\" rowspan=\"3\"\u003e \u003cp\u003ePolysubstance Use\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c3\"\u003e \u003cp\u003e1 substance\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c4\"\u003e \u003cp\u003e42.79%\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colspan=\"1\" nameend=\"c5\" namest=\"c5\"\u003e\u0026nbsp;\u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c3\"\u003e \u003cp\u003e2 substances\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c4\"\u003e \u003cp\u003e34.82%\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colspan=\"1\" nameend=\"c5\" namest=\"c5\"\u003e\u0026nbsp;\u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c3\"\u003e \u003cp\u003e3 substances\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c4\"\u003e \u003cp\u003e22.39%\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colspan=\"1\" nameend=\"c5\" namest=\"c5\"\u003e\u0026nbsp;\u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c1\" morerows=\"3\" rowspan=\"4\"\u003e \u003cp\u003e\u003cb\u003eOutcomes\u003c/b\u003e\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c2\" morerows=\"1\" rowspan=\"2\"\u003e \u003cp\u003eDischarge Status\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c3\"\u003e \u003cp\u003eUse at Discharge\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c4\"\u003e \u003cp\u003e90.85%\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colspan=\"1\" nameend=\"c5\" namest=\"c5\"\u003e\u0026nbsp;\u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c3\"\u003e \u003cp\u003eAbstinent\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c4\"\u003e \u003cp\u003e9.15%\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colspan=\"1\" nameend=\"c5\" namest=\"c5\"\u003e\u0026nbsp;\u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c2\" morerows=\"1\" rowspan=\"2\"\u003e \u003cp\u003eTreatment Completion\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c3\"\u003e \u003cp\u003eYes\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c4\"\u003e \u003cp\u003e42.85%\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colspan=\"1\" nameend=\"c5\" namest=\"c5\"\u003e\u0026nbsp;\u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c3\"\u003e \u003cp\u003eNo\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c4\"\u003e \u003cp\u003e57.15%\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colspan=\"1\" nameend=\"c5\" namest=\"c5\"\u003e\u0026nbsp;\u003c/td\u003e \u003c/tr\u003e \u003c/tbody\u003e \u003c/colgroup\u003e \u003c/table\u003e\u003c/div\u003e \u003c/p\u003e\n\u003ch3\u003eSubstance Use at Discharge\u003c/h3\u003e\n\u003cp\u003e \u003cem\u003eSDOH.\u003c/em\u003e As shown in Table\u0026nbsp;\u003cspan refid=\"Tab2\" class=\"InternalRef\"\u003e2\u003c/span\u003e, several SDOH were significantly associated with substance use at discharge. Risk of continued use upon discharge was higher among individuals who were unemployed, had attained some college education or higher, had a recent arrest history, or were entering treatment for the first time. In contrast, having either public or private health insurance coverage, compared to no insurance, was associated with lower risk of substance use at discharge. While these patterns were generally consistent across sexes, some differences in the strength of the associations were observed. Unemployment and recent arrests were linked to increased risk of continued substance use at discharge for both men and women, with effects more pronounced in women. Higher education levels and lack of prior treatment were also associated with increased risk of substance use upon discharge in both sexes but showed stronger effects in men. Health insurance coverage was protective across sexes, with a slightly stronger protective effect in women. Housing status, marital status, and treatment duration were not significantly associated with substance use at discharge in either sex.\u003c/p\u003e \u003cp\u003e \u003cdiv class=\"gridtable\"\u003e\u003ctable float=\"Yes\" id=\"Tab2\" border=\"1\"\u003e \u003ccaption language=\"En\"\u003e \u003cdiv class=\"CaptionNumber\"\u003eTable 2\u003c/div\u003e \u003cdiv class=\"CaptionContent\"\u003e \u003cp\u003eOdds Ratios for Predictors of \u003cb\u003eSubstance Use at Discharge\u003c/b\u003e, Stratified by Sex\u003c/p\u003e \u003c/div\u003e \u003c/caption\u003e \u003ccolgroup cols=\"10\"\u003e \u003cdiv align=\"left\" class=\"colspec\" colname=\"c1\" colnum=\"1\"\u003e\u003c/div\u003e \u003cdiv align=\"left\" class=\"colspec\" colname=\"c2\" colnum=\"2\"\u003e\u003c/div\u003e \u003cdiv align=\"left\" class=\"colspec\" colname=\"c3\" colnum=\"3\"\u003e\u003c/div\u003e \u003cdiv align=\"left\" class=\"colspec\" colname=\"c4\" colnum=\"4\"\u003e\u003c/div\u003e \u003cdiv align=\"left\" class=\"colspec\" colname=\"c5\" colnum=\"5\"\u003e\u003c/div\u003e \u003cdiv align=\"left\" class=\"colspec\" colname=\"c6\" colnum=\"6\"\u003e\u003c/div\u003e \u003cdiv align=\"left\" class=\"colspec\" colname=\"c7\" colnum=\"7\"\u003e\u003c/div\u003e \u003cdiv align=\"left\" class=\"colspec\" colname=\"c8\" colnum=\"8\"\u003e\u003c/div\u003e \u003cdiv align=\"left\" class=\"colspec\" colname=\"c9\" colnum=\"9\"\u003e\u003c/div\u003e \u003cdiv align=\"left\" class=\"colspec\" colname=\"c10\" colnum=\"10\"\u003e\u003c/div\u003e \u003cthead\u003e \u003ctr\u003e \u003cth align=\"left\" colname=\"c1\"\u003e\u0026nbsp;\u003c/th\u003e \u003cth align=\"left\" colname=\"c2\"\u003e\u0026nbsp;\u003c/th\u003e \u003cth align=\"left\" colname=\"c3\"\u003e\u0026nbsp;\u003c/th\u003e \u003cth align=\"left\" colname=\"c4\"\u003e\u0026nbsp;\u003c/th\u003e \u003cth align=\"left\" colspan=\"2\" nameend=\"c6\" namest=\"c5\"\u003e \u003cp\u003eMen\u003c/p\u003e \u003c/th\u003e \u003cth align=\"left\" colspan=\"2\" nameend=\"c8\" namest=\"c7\"\u003e \u003cp\u003eWomen\u003c/p\u003e \u003c/th\u003e \u003cth align=\"left\" colspan=\"2\" nameend=\"c10\" namest=\"c9\"\u003e\u0026nbsp;\u003c/th\u003e \u003c/tr\u003e \u003ctr\u003e \u003cth align=\"left\" colname=\"c1\"\u003e\u0026nbsp;\u003c/th\u003e \u003cth align=\"left\" colname=\"c2\"\u003e \u003cp\u003ePredictor\u003c/p\u003e \u003c/th\u003e \u003cth align=\"left\" colname=\"c3\"\u003e \u003cp\u003eLevel\u003c/p\u003e \u003c/th\u003e \u003cth align=\"left\" colname=\"c4\"\u003e \u003cp\u003eOverall Interaction Significance with Sex\u003c/p\u003e \u003c/th\u003e \u003cth align=\"left\" colspan=\"2\" nameend=\"c6\" namest=\"c5\"\u003e \u003cp\u003eOR (95% CI)\u003c/p\u003e \u003c/th\u003e \u003cth align=\"left\" colspan=\"2\" nameend=\"c8\" namest=\"c7\"\u003e \u003cp\u003eOR (95% CI)\u003c/p\u003e \u003c/th\u003e \u003cth align=\"left\" colname=\"c9\"\u003e \u003cp\u003eMen vs Women Comparison\u003c/p\u003e \u003cp\u003eOR (95% CI); Males\u0026thinsp;=\u0026thinsp;REF\u003c/p\u003e \u003c/th\u003e \u003cth align=\"left\" colspan=\"1\" nameend=\"c10\" namest=\"c10\"\u003e\u0026nbsp;\u003c/th\u003e \u003c/tr\u003e \u003c/thead\u003e \u003ctbody\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c1\" morerows=\"16\" rowspan=\"17\"\u003e \u003cp\u003e\u003cb\u003eSocial Determinants of Health\u003c/b\u003e\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c2\" morerows=\"1\" rowspan=\"2\"\u003e \u003cp\u003eEmployment\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c3\"\u003e \u003cp\u003eEmployed\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c4\" morerows=\"1\" rowspan=\"2\"\u003e \u003cp\u003e\u0026lt;\u0026thinsp;.001\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c5\"\u003e \u003cp\u003eREF\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colspan=\"2\" nameend=\"c7\" namest=\"c6\"\u003e \u003cp\u003eREF\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colspan=\"2\" nameend=\"c9\" namest=\"c8\"\u003e\u0026nbsp;\u003c/td\u003e \u003ctd align=\"left\" colspan=\"1\" nameend=\"c10\" namest=\"c10\"\u003e\u0026nbsp;\u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c3\"\u003e \u003cp\u003eUnemployed\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c5\"\u003e \u003cp\u003e1.13 (1.12, 1.14)\u003csup\u003ea\u003c/sup\u003e\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colspan=\"2\" nameend=\"c7\" namest=\"c6\"\u003e \u003cp\u003e1.25 (1.24, 1.27)\u003csup\u003ea\u003c/sup\u003e\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colspan=\"2\" nameend=\"c9\" namest=\"c8\"\u003e \u003cp\u003e1.08 (1.07, 1.10)\u003csup\u003ea\u003c/sup\u003e\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colspan=\"1\" nameend=\"c10\" namest=\"c10\"\u003e\u0026nbsp;\u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c2\" morerows=\"1\" rowspan=\"2\"\u003e \u003cp\u003eEducation\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c3\"\u003e \u003cp\u003eHigh School or less\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c4\" morerows=\"1\" rowspan=\"2\"\u003e \u003cp\u003e\u0026lt;\u0026thinsp;.001\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c5\"\u003e \u003cp\u003eREF\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colspan=\"2\" nameend=\"c7\" namest=\"c6\"\u003e \u003cp\u003eREF\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colspan=\"2\" nameend=\"c9\" namest=\"c8\"\u003e\u0026nbsp;\u003c/td\u003e \u003ctd align=\"left\" colspan=\"1\" nameend=\"c10\" namest=\"c10\"\u003e\u0026nbsp;\u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c3\"\u003e \u003cp\u003eSome College or more\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c5\"\u003e \u003cp\u003e1.33 (1.32, 1.34)\u003csup\u003ea\u003c/sup\u003e\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colspan=\"2\" nameend=\"c7\" namest=\"c6\"\u003e \u003cp\u003e1.22 (1.21, 1.24)\u003csup\u003ea\u003c/sup\u003e\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colspan=\"2\" nameend=\"c9\" namest=\"c8\"\u003e \u003cp\u003e0.92 (0.90, 0.93)\u003csup\u003ea\u003c/sup\u003e\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colspan=\"1\" nameend=\"c10\" namest=\"c10\"\u003e\u0026nbsp;\u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c2\" morerows=\"1\" rowspan=\"2\"\u003e \u003cp\u003eHousing\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c3\"\u003e \u003cp\u003eHoused\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c4\" morerows=\"1\" rowspan=\"2\"\u003e \u003cp\u003en.s.\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c5\"\u003e\u0026nbsp;\u003c/td\u003e \u003ctd align=\"left\" colspan=\"2\" nameend=\"c7\" namest=\"c6\"\u003e\u0026nbsp;\u003c/td\u003e \u003ctd align=\"left\" colspan=\"2\" nameend=\"c9\" namest=\"c8\"\u003e\u0026nbsp;\u003c/td\u003e \u003ctd align=\"left\" colspan=\"1\" nameend=\"c10\" namest=\"c10\"\u003e\u0026nbsp;\u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c3\"\u003e \u003cp\u003eUnhoused\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c5\"\u003e\u0026nbsp;\u003c/td\u003e \u003ctd align=\"left\" colspan=\"2\" nameend=\"c7\" namest=\"c6\"\u003e\u0026nbsp;\u003c/td\u003e \u003ctd align=\"left\" colspan=\"2\" nameend=\"c9\" namest=\"c8\"\u003e\u0026nbsp;\u003c/td\u003e \u003ctd align=\"left\" colspan=\"1\" nameend=\"c10\" namest=\"c10\"\u003e\u0026nbsp;\u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c2\" morerows=\"1\" rowspan=\"2\"\u003e \u003cp\u003eRecent Arrests\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c3\"\u003e \u003cp\u003eNone\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c4\" morerows=\"1\" rowspan=\"2\"\u003e \u003cp\u003e\u0026lt;\u0026thinsp;.001\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c5\"\u003e \u003cp\u003eREF\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colspan=\"2\" nameend=\"c7\" namest=\"c6\"\u003e \u003cp\u003eREF\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colspan=\"2\" nameend=\"c9\" namest=\"c8\"\u003e\u0026nbsp;\u003c/td\u003e \u003ctd align=\"left\" colspan=\"1\" nameend=\"c10\" namest=\"c10\"\u003e\u0026nbsp;\u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c3\"\u003e \u003cp\u003eYes\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c5\"\u003e \u003cp\u003e1.23 (1.21, 1.26)\u003csup\u003ea\u003c/sup\u003e\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colspan=\"2\" nameend=\"c7\" namest=\"c6\"\u003e \u003cp\u003e1.27 (1.25, 1.30)\u003csup\u003ea\u003c/sup\u003e\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colspan=\"2\" nameend=\"c9\" namest=\"c8\"\u003e \u003cp\u003e1.05 (1.02, 1.08)\u003csup\u003ea\u003c/sup\u003e\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colspan=\"1\" nameend=\"c10\" namest=\"c10\"\u003e\u0026nbsp;\u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c2\" morerows=\"1\" rowspan=\"2\"\u003e \u003cp\u003eMarital Status\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c3\"\u003e \u003cp\u003eMarried\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c4\" morerows=\"1\" rowspan=\"2\"\u003e \u003cp\u003en.s.\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c5\"\u003e\u0026nbsp;\u003c/td\u003e \u003ctd align=\"left\" colspan=\"2\" nameend=\"c7\" namest=\"c6\"\u003e\u0026nbsp;\u003c/td\u003e \u003ctd align=\"left\" colspan=\"2\" nameend=\"c9\" namest=\"c8\"\u003e\u0026nbsp;\u003c/td\u003e \u003ctd align=\"left\" colspan=\"1\" nameend=\"c10\" namest=\"c10\"\u003e\u0026nbsp;\u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c3\"\u003e \u003cp\u003eNot Married\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c5\"\u003e\u0026nbsp;\u003c/td\u003e \u003ctd align=\"left\" colspan=\"2\" nameend=\"c7\" namest=\"c6\"\u003e\u0026nbsp;\u003c/td\u003e \u003ctd align=\"left\" colspan=\"2\" nameend=\"c9\" namest=\"c8\"\u003e\u0026nbsp;\u003c/td\u003e \u003ctd align=\"left\" colspan=\"1\" nameend=\"c10\" namest=\"c10\"\u003e\u0026nbsp;\u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c2\" morerows=\"1\" rowspan=\"2\"\u003e \u003cp\u003ePrior Treatment\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c3\"\u003e \u003cp\u003eHad Treatment\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c4\" morerows=\"1\" rowspan=\"2\"\u003e \u003cp\u003e\u0026lt;\u0026thinsp;.001\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c5\"\u003e \u003cp\u003eREF\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colspan=\"2\" nameend=\"c7\" namest=\"c6\"\u003e \u003cp\u003eREF\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colspan=\"2\" nameend=\"c9\" namest=\"c8\"\u003e\u0026nbsp;\u003c/td\u003e \u003ctd align=\"left\" colspan=\"1\" nameend=\"c10\" namest=\"c10\"\u003e\u0026nbsp;\u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c3\"\u003e \u003cp\u003eNo Prior Treatment\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c5\"\u003e \u003cp\u003e1.31 (1.30, 1.32)\u003csup\u003ea\u003c/sup\u003e\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colspan=\"2\" nameend=\"c7\" namest=\"c6\"\u003e \u003cp\u003e1.22 (1.21, 1.23)\u003csup\u003ea\u003c/sup\u003e\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colspan=\"2\" nameend=\"c9\" namest=\"c8\"\u003e \u003cp\u003e0.94 (0.93, 0.95)\u003csup\u003ea\u003c/sup\u003e\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colspan=\"1\" nameend=\"c10\" namest=\"c10\"\u003e\u0026nbsp;\u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c2\" morerows=\"2\" rowspan=\"3\"\u003e \u003cp\u003eHealth Insurance Type\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c3\"\u003e \u003cp\u003eNone\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c4\" morerows=\"2\" rowspan=\"3\"\u003e \u003cp\u003e\u0026lt;\u0026thinsp;.001\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c5\"\u003e \u003cp\u003eREF\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colspan=\"2\" nameend=\"c7\" namest=\"c6\"\u003e \u003cp\u003eREF\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colspan=\"2\" nameend=\"c9\" namest=\"c8\"\u003e\u0026nbsp;\u003c/td\u003e \u003ctd align=\"left\" colspan=\"1\" nameend=\"c10\" namest=\"c10\"\u003e\u0026nbsp;\u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c3\"\u003e \u003cp\u003ePrivate\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c5\"\u003e \u003cp\u003e0.21 (0.21, 0.22)\u003csup\u003ea\u003c/sup\u003e\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colspan=\"2\" nameend=\"c7\" namest=\"c6\"\u003e \u003cp\u003e0.17 (0.16, 0.17)\u003csup\u003ea\u003c/sup\u003e\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colspan=\"2\" nameend=\"c9\" namest=\"c8\"\u003e \u003cp\u003e0.76 (0.74, 0.78)\u003csup\u003ea\u003c/sup\u003e\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colspan=\"1\" nameend=\"c10\" namest=\"c10\"\u003e\u0026nbsp;\u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c3\"\u003e \u003cp\u003ePublic/Government\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c5\"\u003e \u003cp\u003e0.28 (0.28, 0.28)\u003csup\u003ea\u003c/sup\u003e\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colspan=\"2\" nameend=\"c7\" namest=\"c6\"\u003e \u003cp\u003e0.25 (0.24, 0.25)\u003csup\u003ea\u003c/sup\u003e\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colspan=\"2\" nameend=\"c9\" namest=\"c8\"\u003e \u003cp\u003e0.87 (0.85, 0.88)\u003csup\u003ea\u003c/sup\u003e\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colspan=\"1\" nameend=\"c10\" namest=\"c10\"\u003e\u0026nbsp;\u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c2\" morerows=\"1\" rowspan=\"2\"\u003e \u003cp\u003eTreatment Duration\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c3\"\u003e \u003cp\u003e\u0026lt;\u0026thinsp;30 days\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c4\" morerows=\"1\" rowspan=\"2\"\u003e \u003cp\u003en.s.\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c5\"\u003e\u0026nbsp;\u003c/td\u003e \u003ctd align=\"left\" colspan=\"2\" nameend=\"c7\" namest=\"c6\"\u003e\u0026nbsp;\u003c/td\u003e \u003ctd align=\"left\" colspan=\"2\" nameend=\"c9\" namest=\"c8\"\u003e\u0026nbsp;\u003c/td\u003e \u003ctd align=\"left\" colspan=\"1\" nameend=\"c10\" namest=\"c10\"\u003e\u0026nbsp;\u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c3\"\u003e \u003cp\u003e31\u0026thinsp;+\u0026thinsp;days\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c5\"\u003e\u0026nbsp;\u003c/td\u003e \u003ctd align=\"left\" colspan=\"2\" nameend=\"c7\" namest=\"c6\"\u003e\u0026nbsp;\u003c/td\u003e \u003ctd align=\"left\" colspan=\"2\" nameend=\"c9\" namest=\"c8\"\u003e\u0026nbsp;\u003c/td\u003e \u003ctd align=\"left\" colspan=\"1\" nameend=\"c10\" namest=\"c10\"\u003e\u0026nbsp;\u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c1\" morerows=\"7\" rowspan=\"8\"\u003e \u003cp\u003e\u003cb\u003eSUD Severity\u003c/b\u003e\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c2\" morerows=\"2\" rowspan=\"3\"\u003e \u003cp\u003eAge at First Use\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c3\"\u003e \u003cp\u003e\u0026lt;\u0026thinsp;17 years\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c4\" morerows=\"2\" rowspan=\"3\"\u003e \u003cp\u003e\u0026lt;\u0026thinsp;.001\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c5\"\u003e \u003cp\u003eREF\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colspan=\"2\" nameend=\"c7\" namest=\"c6\"\u003e \u003cp\u003eREF\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colspan=\"2\" nameend=\"c9\" namest=\"c8\"\u003e\u0026nbsp;\u003c/td\u003e \u003ctd align=\"left\" colspan=\"1\" nameend=\"c10\" namest=\"c10\"\u003e\u0026nbsp;\u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c3\"\u003e \u003cp\u003e18 to 29 years\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c5\"\u003e \u003cp\u003e0.82 (0.81, 0.83)\u003csup\u003ea\u003c/sup\u003e\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colspan=\"2\" nameend=\"c7\" namest=\"c6\"\u003e \u003cp\u003e0.94 (0.93, 0.95)\u003csup\u003ea\u003c/sup\u003e\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colspan=\"2\" nameend=\"c9\" namest=\"c8\"\u003e \u003cp\u003e1.15 (1.13, 1.16)\u003csup\u003ea\u003c/sup\u003e\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colspan=\"1\" nameend=\"c10\" namest=\"c10\"\u003e\u0026nbsp;\u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c3\"\u003e \u003cp\u003e30\u0026thinsp;+\u0026thinsp;years\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c5\"\u003e \u003cp\u003e0.88 (0.87, 0.89)\u003csup\u003ea\u003c/sup\u003e\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colspan=\"2\" nameend=\"c7\" namest=\"c6\"\u003e \u003cp\u003e1.05 (1.03, 1.07)\u003csup\u003ea\u003c/sup\u003e\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colspan=\"2\" nameend=\"c9\" namest=\"c8\"\u003e \u003cp\u003e1.15 (1.13, 1.18)\u003csup\u003ea\u003c/sup\u003e\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colspan=\"1\" nameend=\"c10\" namest=\"c10\"\u003e\u0026nbsp;\u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c2\" morerows=\"1\" rowspan=\"2\"\u003e \u003cp\u003eCo-Occurring\u003c/p\u003e \u003cp\u003ePsychiatric Disorders\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c3\"\u003e \u003cp\u003eNo\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c4\" morerows=\"1\" rowspan=\"2\"\u003e \u003cp\u003e\u0026lt;\u0026thinsp;.001\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c5\"\u003e \u003cp\u003eREF\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colspan=\"2\" nameend=\"c7\" namest=\"c6\"\u003e \u003cp\u003eREF\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colspan=\"2\" nameend=\"c9\" namest=\"c8\"\u003e\u0026nbsp;\u003c/td\u003e \u003ctd align=\"left\" colspan=\"1\" nameend=\"c10\" namest=\"c10\"\u003e\u0026nbsp;\u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c3\"\u003e \u003cp\u003eYes\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c5\"\u003e \u003cp\u003e0.96 (0.95, 0.96)\u003csup\u003ea\u003c/sup\u003e\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colspan=\"2\" nameend=\"c7\" namest=\"c6\"\u003e \u003cp\u003e1.20 (1.18, 1.21)\u003csup\u003ea\u003c/sup\u003e\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colspan=\"2\" nameend=\"c9\" namest=\"c8\"\u003e \u003cp\u003e1.25 (1.24, 1.27)\u003csup\u003ea\u003c/sup\u003e\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colspan=\"1\" nameend=\"c10\" namest=\"c10\"\u003e\u0026nbsp;\u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c2\" morerows=\"2\" rowspan=\"3\"\u003e \u003cp\u003ePolysubstance Use\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c3\"\u003e \u003cp\u003e1 substance\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c4\" morerows=\"2\" rowspan=\"3\"\u003e \u003cp\u003e\u0026lt;\u0026thinsp;.001\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c5\"\u003e \u003cp\u003eREF\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colspan=\"2\" nameend=\"c7\" namest=\"c6\"\u003e \u003cp\u003eREF\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colspan=\"2\" nameend=\"c9\" namest=\"c8\"\u003e\u0026nbsp;\u003c/td\u003e \u003ctd align=\"left\" colspan=\"1\" nameend=\"c10\" namest=\"c10\"\u003e\u0026nbsp;\u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c3\"\u003e \u003cp\u003e2 substances\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c5\"\u003e \u003cp\u003e1.31 (1.30, 1.33)\u003csup\u003ea\u003c/sup\u003e\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colspan=\"2\" nameend=\"c7\" namest=\"c6\"\u003e \u003cp\u003e1.44 (1.42, 1.45)\u003csup\u003ea\u003c/sup\u003e\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colspan=\"2\" nameend=\"c9\" namest=\"c8\"\u003e \u003cp\u003e1.10 (1.08, 1.11)\u003csup\u003ea\u003c/sup\u003e\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colspan=\"1\" nameend=\"c10\" namest=\"c10\"\u003e\u0026nbsp;\u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c3\"\u003e \u003cp\u003e3 substances\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c5\"\u003e \u003cp\u003e1.77 (1.75, 1.79)\u003csup\u003ea\u003c/sup\u003e\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colspan=\"2\" nameend=\"c7\" namest=\"c6\"\u003e \u003cp\u003e2.03 (2.00, 2.06)\u003csup\u003ea\u003c/sup\u003e\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colspan=\"2\" nameend=\"c9\" namest=\"c8\"\u003e \u003cp\u003e1.16 (1.13, 1.18)\u003csup\u003ea\u003c/sup\u003e\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colspan=\"1\" nameend=\"c10\" namest=\"c10\"\u003e\u0026nbsp;\u003c/td\u003e \u003c/tr\u003e \u003c/tbody\u003e \u003c/colgroup\u003e \u003ctfoot\u003e \u003ctr\u003e\u003ctd colspan=\"10\"\u003eNote: Last column shows ORs for Predictor \u0026times; Sex interaction (F vs. M; M\u0026thinsp;=\u0026thinsp;REF); \u003cem\u003ea\u003c/em\u003e\u0026thinsp;=\u0026thinsp;p \u0026lt;\u0026thinsp;.01; \u003cem\u003eb\u003c/em\u003e\u0026thinsp;=\u0026thinsp;p \u0026gt;\u0026thinsp;.01; \u003cem\u003en.s.\u003c/em\u003e = no significant difference.\u003c/td\u003e\u003c/tr\u003e \u003c/tfoot\u003e \u003c/table\u003e\u003c/div\u003e \u003c/p\u003e \u003cp\u003e \u003cem\u003eSUD Severity-Related Predictors.\u003c/em\u003e Several clinical severity factors were associated with greater risk of substance use at discharge. Polysubstance use showed a dose-response relationship, with use of two or more substances increasing risk compared to single-substance use. In contrast, late age of first substance use was generally protective. Individuals who began using their primary substance between ages 18\u0026ndash;29 or after age 30 were less likely to use substances at discharge than those who started before age 17. Psychiatric comorbidities were also associated with elevated risk for substance use at discharge, though not uniformly. These associations varied by sex, where women showed greater vulnerability related to both polysubstance use and co-occurring psychiatric disorders, while the protective effects of later substance use onset were stronger and more consistent among men. Notably, substance use beginning after age 30 was protective for men but associated with elevated risk in women.\u003c/p\u003e\n\u003ch3\u003eTreatment Non-Completion\u003c/h3\u003e\n\u003cp\u003e \u003cem\u003eSDOH.\u003c/em\u003e As presented in Table\u0026nbsp;\u003cspan refid=\"Tab3\" class=\"InternalRef\"\u003e3\u003c/span\u003e, risk of treatment non-completion was higher among individuals who were unemployed, unhoused, unmarried, or entering treatment for the first time. Conversely, having health insurance, whether public or private, was associated with a lower likelihood of dropout. Risk for treatment attrition varied for certain predictors based on sex. Women showed greater risk of not completing treatment associated with unemployment and unstable housing, while men showed greater vulnerability for attrition associated with being unmarried, lacking prior treatment experience, and having a recent arrest. While the sex differences for marital status and prior treatment history were statistically significant, the magnitude of these effects was modest. In contrast, differences by health insurance type were more consistent across sexes. Health insurance coverage reduced dropout risk in both sexes, with public insurance coverage showing a slightly stronger effect among women and private coverage showing modestly stronger effect among men. Education level was not significantly associated with treatment non-completion in either sex.\u003c/p\u003e \u003cp\u003e \u003cdiv class=\"gridtable\"\u003e\u003ctable float=\"Yes\" id=\"Tab3\" border=\"1\"\u003e \u003ccaption language=\"En\"\u003e \u003cdiv class=\"CaptionNumber\"\u003eTable 3\u003c/div\u003e \u003cdiv class=\"CaptionContent\"\u003e \u003cp\u003eOdds Ratios for Predictors of \u003cb\u003eTreatment Non-Completion\u003c/b\u003e, Stratified by Sex\u003c/p\u003e \u003c/div\u003e \u003c/caption\u003e \u003ccolgroup cols=\"15\"\u003e \u003cdiv align=\"left\" class=\"colspec\" colname=\"c1\" colnum=\"1\"\u003e\u003c/div\u003e \u003cdiv align=\"left\" class=\"colspec\" colname=\"c2\" colnum=\"2\"\u003e\u003c/div\u003e \u003cdiv align=\"left\" class=\"colspec\" colname=\"c3\" colnum=\"3\"\u003e\u003c/div\u003e \u003cdiv align=\"left\" class=\"colspec\" colname=\"c4\" colnum=\"4\"\u003e\u003c/div\u003e \u003cdiv align=\"left\" class=\"colspec\" colname=\"c5\" colnum=\"5\"\u003e\u003c/div\u003e \u003cdiv align=\"left\" class=\"colspec\" colname=\"c6\" colnum=\"6\"\u003e\u003c/div\u003e \u003cdiv align=\"left\" class=\"colspec\" colname=\"c7\" colnum=\"7\"\u003e\u003c/div\u003e \u003cdiv align=\"left\" class=\"colspec\" colname=\"c8\" colnum=\"8\"\u003e\u003c/div\u003e \u003cdiv align=\"left\" class=\"colspec\" colname=\"c9\" colnum=\"9\"\u003e\u003c/div\u003e \u003cdiv align=\"left\" class=\"colspec\" colname=\"c10\" colnum=\"10\"\u003e\u003c/div\u003e \u003cdiv align=\"left\" class=\"colspec\" colname=\"c11\" colnum=\"11\"\u003e\u003c/div\u003e \u003cdiv align=\"left\" class=\"colspec\" colname=\"c12\" colnum=\"12\"\u003e\u003c/div\u003e \u003cdiv align=\"left\" class=\"colspec\" colname=\"c13\" colnum=\"13\"\u003e\u003c/div\u003e \u003cdiv align=\"left\" class=\"colspec\" colname=\"c14\" colnum=\"14\"\u003e\u003c/div\u003e \u003cdiv align=\"left\" class=\"colspec\" colname=\"c15\" colnum=\"15\"\u003e\u003c/div\u003e \u003cthead\u003e \u003ctr\u003e \u003cth align=\"left\" colname=\"c1\"\u003e\u0026nbsp;\u003c/th\u003e \u003cth align=\"left\" colname=\"c2\"\u003e\u0026nbsp;\u003c/th\u003e \u003cth align=\"left\" colspan=\"2\" nameend=\"c4\" namest=\"c3\"\u003e\u0026nbsp;\u003c/th\u003e \u003cth align=\"left\" colspan=\"2\" nameend=\"c6\" namest=\"c5\"\u003e\u0026nbsp;\u003c/th\u003e \u003cth align=\"left\" colspan=\"2\" nameend=\"c8\" namest=\"c7\"\u003e \u003cp\u003eMen\u003c/p\u003e \u003c/th\u003e \u003cth align=\"left\" colspan=\"2\" nameend=\"c10\" namest=\"c9\"\u003e \u003cp\u003eWomen\u003c/p\u003e \u003c/th\u003e \u003cth align=\"left\" colspan=\"5\" nameend=\"c15\" namest=\"c11\"\u003e\u0026nbsp;\u003c/th\u003e \u003c/tr\u003e \u003ctr\u003e \u003cth align=\"left\" colname=\"c1\"\u003e\u0026nbsp;\u003c/th\u003e \u003cth align=\"left\" colname=\"c2\"\u003e \u003cp\u003ePredictor\u003c/p\u003e \u003c/th\u003e \u003cth align=\"left\" colname=\"c3\"\u003e \u003cp\u003eLevel\u003c/p\u003e \u003c/th\u003e \u003cth align=\"left\" colspan=\"2\" nameend=\"c5\" namest=\"c4\"\u003e \u003cp\u003eOverall Interaction Significance with Sex\u003c/p\u003e \u003c/th\u003e \u003cth align=\"left\" colspan=\"2\" nameend=\"c7\" namest=\"c6\"\u003e \u003cp\u003eOR (95% CI)\u003c/p\u003e \u003c/th\u003e \u003cth align=\"left\" colspan=\"2\" nameend=\"c9\" namest=\"c8\"\u003e \u003cp\u003eOR (95% CI)\u003c/p\u003e \u003c/th\u003e \u003cth align=\"left\" colspan=\"5\" nameend=\"c14\" namest=\"c10\"\u003e \u003cp\u003eMen vs Women Comparison\u003c/p\u003e \u003cp\u003eOR (95% CI); Males\u0026thinsp;=\u0026thinsp;REF\u003c/p\u003e \u003c/th\u003e \u003cth align=\"left\" colspan=\"1\" nameend=\"c15\" namest=\"c15\"\u003e\u0026nbsp;\u003c/th\u003e \u003c/tr\u003e \u003c/thead\u003e \u003ctbody\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c1\" morerows=\"16\" rowspan=\"17\"\u003e \u003cp\u003e\u003cb\u003eSocial Determinants of Health\u003c/b\u003e\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c2\" morerows=\"1\" rowspan=\"2\"\u003e \u003cp\u003eEmployment\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c3\"\u003e \u003cp\u003eEmployed\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colspan=\"2\" morerows=\"1\" nameend=\"c5\" namest=\"c4\" rowspan=\"2\"\u003e \u003cp\u003e\u0026lt;\u0026thinsp;.001\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colspan=\"2\" nameend=\"c7\" namest=\"c6\"\u003e \u003cp\u003eREF\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colspan=\"2\" nameend=\"c9\" namest=\"c8\"\u003e \u003cp\u003eREF\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colspan=\"3\" nameend=\"c12\" namest=\"c10\"\u003e\u0026nbsp;\u003c/td\u003e \u003ctd align=\"left\" colspan=\"3\" nameend=\"c15\" namest=\"c13\"\u003e\u0026nbsp;\u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c3\"\u003e \u003cp\u003eUnemployed\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colspan=\"2\" nameend=\"c7\" namest=\"c6\"\u003e \u003cp\u003e1.53 (1.53, 1.54)\u003csup\u003ea\u003c/sup\u003e\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colspan=\"2\" nameend=\"c9\" namest=\"c8\"\u003e \u003cp\u003e1.66 (1.65, 1.67)\u003csup\u003ea\u003c/sup\u003e\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colspan=\"3\" nameend=\"c12\" namest=\"c10\"\u003e \u003cp\u003e1.08 (1.07, 1.09)\u003csup\u003ea\u003c/sup\u003e\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colspan=\"3\" nameend=\"c15\" namest=\"c13\"\u003e\u0026nbsp;\u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c2\" morerows=\"1\" rowspan=\"2\"\u003e \u003cp\u003eEducation\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c3\"\u003e \u003cp\u003eHigh School or less\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colspan=\"2\" morerows=\"1\" nameend=\"c5\" namest=\"c4\" rowspan=\"2\"\u003e \u003cp\u003en.s.\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colspan=\"2\" nameend=\"c7\" namest=\"c6\"\u003e\u0026nbsp;\u003c/td\u003e \u003ctd align=\"left\" colspan=\"2\" nameend=\"c9\" namest=\"c8\"\u003e\u0026nbsp;\u003c/td\u003e \u003ctd align=\"left\" colspan=\"3\" nameend=\"c12\" namest=\"c10\"\u003e\u0026nbsp;\u003c/td\u003e \u003ctd align=\"left\" colspan=\"3\" nameend=\"c15\" namest=\"c13\"\u003e\u0026nbsp;\u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c3\"\u003e \u003cp\u003eSome College or more\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colspan=\"2\" nameend=\"c7\" namest=\"c6\"\u003e\u0026nbsp;\u003c/td\u003e \u003ctd align=\"left\" colspan=\"2\" nameend=\"c9\" namest=\"c8\"\u003e\u0026nbsp;\u003c/td\u003e \u003ctd align=\"left\" colspan=\"3\" nameend=\"c12\" namest=\"c10\"\u003e\u0026nbsp;\u003c/td\u003e \u003ctd align=\"left\" colspan=\"3\" nameend=\"c15\" namest=\"c13\"\u003e\u0026nbsp;\u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c2\" morerows=\"1\" rowspan=\"2\"\u003e \u003cp\u003eHousing\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c3\"\u003e \u003cp\u003eHoused\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colspan=\"2\" morerows=\"1\" nameend=\"c5\" namest=\"c4\" rowspan=\"2\"\u003e \u003cp\u003e\u0026lt;\u0026thinsp;.001\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colspan=\"2\" nameend=\"c7\" namest=\"c6\"\u003e \u003cp\u003eREF\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colspan=\"2\" nameend=\"c9\" namest=\"c8\"\u003e \u003cp\u003eREF\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colspan=\"3\" nameend=\"c12\" namest=\"c10\"\u003e\u0026nbsp;\u003c/td\u003e \u003ctd align=\"left\" colspan=\"3\" nameend=\"c15\" namest=\"c13\"\u003e\u0026nbsp;\u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c3\"\u003e \u003cp\u003eUnhoused\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colspan=\"2\" nameend=\"c7\" namest=\"c6\"\u003e \u003cp\u003e1.11 (1.11, 1.12)\u003csup\u003ea\u003c/sup\u003e\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colspan=\"2\" nameend=\"c9\" namest=\"c8\"\u003e \u003cp\u003e1.34 (1.33, 1.36)\u003csup\u003ea\u003c/sup\u003e\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colspan=\"3\" nameend=\"c12\" namest=\"c10\"\u003e \u003cp\u003e1.21 (1.19, 1.22)\u003csup\u003ea\u003c/sup\u003e\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colspan=\"3\" nameend=\"c15\" namest=\"c13\"\u003e\u0026nbsp;\u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c2\" morerows=\"1\" rowspan=\"2\"\u003e \u003cp\u003eRecent Arrests\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c3\"\u003e \u003cp\u003eNone\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colspan=\"2\" morerows=\"1\" nameend=\"c5\" namest=\"c4\" rowspan=\"2\"\u003e \u003cp\u003e\u0026lt;\u0026thinsp;.001\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colspan=\"2\" nameend=\"c7\" namest=\"c6\"\u003e \u003cp\u003eREF\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colspan=\"2\" nameend=\"c9\" namest=\"c8\"\u003e \u003cp\u003eREF\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colspan=\"3\" nameend=\"c12\" namest=\"c10\"\u003e\u0026nbsp;\u003c/td\u003e \u003ctd align=\"left\" colspan=\"3\" nameend=\"c15\" namest=\"c13\"\u003e\u0026nbsp;\u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c3\"\u003e \u003cp\u003eYes\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colspan=\"2\" nameend=\"c7\" namest=\"c6\"\u003e \u003cp\u003e1.19 (1.18, 1.20)\u003csup\u003ea\u003c/sup\u003e\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colspan=\"2\" nameend=\"c9\" namest=\"c8\"\u003e \u003cp\u003e1.01 (1.00, 1.02)\u003csup\u003eb\u003c/sup\u003e\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colspan=\"3\" nameend=\"c12\" namest=\"c10\"\u003e \u003cp\u003e0.85 (0.84, 0.87)\u003csup\u003ea\u003c/sup\u003e\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colspan=\"3\" nameend=\"c15\" namest=\"c13\"\u003e\u0026nbsp;\u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c2\" morerows=\"1\" rowspan=\"2\"\u003e \u003cp\u003eMarital Status\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c3\"\u003e \u003cp\u003eMarried\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colspan=\"2\" morerows=\"1\" nameend=\"c5\" namest=\"c4\" rowspan=\"2\"\u003e \u003cp\u003e.001\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colspan=\"2\" nameend=\"c7\" namest=\"c6\"\u003e \u003cp\u003eREF\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colspan=\"2\" nameend=\"c9\" namest=\"c8\"\u003e \u003cp\u003eREF\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colspan=\"3\" nameend=\"c12\" namest=\"c10\"\u003e\u0026nbsp;\u003c/td\u003e \u003ctd align=\"left\" colspan=\"3\" nameend=\"c15\" namest=\"c13\"\u003e\u0026nbsp;\u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c3\"\u003e \u003cp\u003eNot Married\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colspan=\"2\" nameend=\"c7\" namest=\"c6\"\u003e \u003cp\u003e1.08 (1.07, 1.08)\u003csup\u003ea\u003c/sup\u003e\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colspan=\"2\" nameend=\"c9\" namest=\"c8\"\u003e \u003cp\u003e1.06 (1.05, 1.07)\u003csup\u003ea\u003c/sup\u003e\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colspan=\"3\" nameend=\"c12\" namest=\"c10\"\u003e \u003cp\u003e0.98 (0.97, 0.99)\u003csup\u003ea\u003c/sup\u003e\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colspan=\"3\" nameend=\"c15\" namest=\"c13\"\u003e\u0026nbsp;\u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c2\" morerows=\"1\" rowspan=\"2\"\u003e \u003cp\u003ePrior Treatment\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c3\"\u003e \u003cp\u003eHad Treatment\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colspan=\"2\" morerows=\"1\" nameend=\"c5\" namest=\"c4\" rowspan=\"2\"\u003e \u003cp\u003e\u0026lt;\u0026thinsp;.001\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colspan=\"2\" nameend=\"c7\" namest=\"c6\"\u003e \u003cp\u003eREF\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colspan=\"2\" nameend=\"c9\" namest=\"c8\"\u003e \u003cp\u003eREF\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colspan=\"3\" nameend=\"c12\" namest=\"c10\"\u003e\u0026nbsp;\u003c/td\u003e \u003ctd align=\"left\" colspan=\"3\" nameend=\"c15\" namest=\"c13\"\u003e\u0026nbsp;\u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c3\"\u003e \u003cp\u003eNo Previous Treatment\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colspan=\"2\" nameend=\"c7\" namest=\"c6\"\u003e \u003cp\u003e1.16 (1.16, 1.17)\u003csup\u003ea\u003c/sup\u003e\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colspan=\"2\" nameend=\"c9\" namest=\"c8\"\u003e \u003cp\u003e1.15 (1.14, 1.15)\u003csup\u003ea\u003c/sup\u003e\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colspan=\"3\" nameend=\"c12\" namest=\"c10\"\u003e \u003cp\u003e0.99 (0.98, 0.99)\u003csup\u003ea\u003c/sup\u003e\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colspan=\"3\" nameend=\"c15\" namest=\"c13\"\u003e\u0026nbsp;\u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c2\" morerows=\"2\" rowspan=\"3\"\u003e \u003cp\u003eHealth Insurance Type\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c3\"\u003e \u003cp\u003eNone\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colspan=\"2\" morerows=\"2\" nameend=\"c5\" namest=\"c4\" rowspan=\"3\"\u003e \u003cp\u003e\u0026lt;\u0026thinsp;.001\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colspan=\"2\" nameend=\"c7\" namest=\"c6\"\u003e \u003cp\u003eREF\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colspan=\"2\" nameend=\"c9\" namest=\"c8\"\u003e \u003cp\u003eREF\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colspan=\"3\" nameend=\"c12\" namest=\"c10\"\u003e\u0026nbsp;\u003c/td\u003e \u003ctd align=\"left\" colspan=\"3\" nameend=\"c15\" namest=\"c13\"\u003e\u0026nbsp;\u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c3\"\u003e \u003cp\u003ePrivate\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colspan=\"2\" nameend=\"c7\" namest=\"c6\"\u003e \u003cp\u003e0.65 (0.64, 0.65)\u003csup\u003ea\u003c/sup\u003e\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colspan=\"2\" nameend=\"c9\" namest=\"c8\"\u003e \u003cp\u003e0.67 (0.66, 0.68)\u003csup\u003ea\u003c/sup\u003e\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colspan=\"3\" nameend=\"c12\" namest=\"c10\"\u003e \u003cp\u003e1.04 (1.02, 1.06)\u003csup\u003ea\u003c/sup\u003e\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colspan=\"3\" nameend=\"c15\" namest=\"c13\"\u003e\u0026nbsp;\u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c3\"\u003e \u003cp\u003ePublic/Government\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colspan=\"2\" nameend=\"c7\" namest=\"c6\"\u003e \u003cp\u003e0.77 (0.77, 0.78)\u003csup\u003ea\u003c/sup\u003e\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colspan=\"2\" nameend=\"c9\" namest=\"c8\"\u003e \u003cp\u003e0.72 (0.72, 0.73)\u003csup\u003ea\u003c/sup\u003e\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colspan=\"3\" nameend=\"c12\" namest=\"c10\"\u003e \u003cp\u003e0.93 (0.92, 0.94)\u003csup\u003ea\u003c/sup\u003e\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colspan=\"3\" nameend=\"c15\" namest=\"c13\"\u003e\u0026nbsp;\u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c2\" morerows=\"1\" rowspan=\"2\"\u003e \u003cp\u003eTreatment Duration\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c3\"\u003e \u003cp\u003e\u0026lt;\u0026thinsp;30 days\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colspan=\"2\" morerows=\"1\" nameend=\"c5\" namest=\"c4\" rowspan=\"2\"\u003e \u003cp\u003e\u0026lt;\u0026thinsp;.001\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colspan=\"2\" nameend=\"c7\" namest=\"c6\"\u003e \u003cp\u003eREF\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colspan=\"2\" nameend=\"c9\" namest=\"c8\"\u003e \u003cp\u003eREF\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colspan=\"3\" nameend=\"c12\" namest=\"c10\"\u003e\u0026nbsp;\u003c/td\u003e \u003ctd align=\"left\" colspan=\"3\" nameend=\"c15\" namest=\"c13\"\u003e\u0026nbsp;\u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c3\"\u003e \u003cp\u003e31\u0026thinsp;+\u0026thinsp;days\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colspan=\"2\" nameend=\"c7\" namest=\"c6\"\u003e \u003cp\u003e1.02 (1.01, 1.02)\u003csup\u003ea\u003c/sup\u003e\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colspan=\"2\" nameend=\"c9\" namest=\"c8\"\u003e \u003cp\u003e0.96 (0.95, 0.96)\u003csup\u003ea\u003c/sup\u003e\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colspan=\"3\" nameend=\"c12\" namest=\"c10\"\u003e \u003cp\u003e0.94 (0.94, 0.95)\u003csup\u003ea\u003c/sup\u003e\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colspan=\"3\" nameend=\"c15\" namest=\"c13\"\u003e\u0026nbsp;\u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c1\" morerows=\"7\" rowspan=\"8\"\u003e \u003cp\u003e\u003cb\u003eSUD Severity\u003c/b\u003e\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c2\" morerows=\"2\" rowspan=\"3\"\u003e \u003cp\u003eAge at First Use\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c3\"\u003e \u003cp\u003e\u0026lt;\u0026thinsp;17 years\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colspan=\"2\" morerows=\"2\" nameend=\"c5\" namest=\"c4\" rowspan=\"3\"\u003e \u003cp\u003e\u0026lt;\u0026thinsp;.001\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colspan=\"2\" nameend=\"c7\" namest=\"c6\"\u003e \u003cp\u003eREF\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colspan=\"2\" nameend=\"c9\" namest=\"c8\"\u003e \u003cp\u003eREF\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colspan=\"3\" nameend=\"c12\" namest=\"c10\"\u003e\u0026nbsp;\u003c/td\u003e \u003ctd align=\"left\" colspan=\"3\" nameend=\"c15\" namest=\"c13\"\u003e\u0026nbsp;\u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c3\"\u003e \u003cp\u003e18 to 29 years\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colspan=\"2\" nameend=\"c7\" namest=\"c6\"\u003e \u003cp\u003e1.18 (1.17, 1.18)\u003csup\u003ea\u003c/sup\u003e\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colspan=\"2\" nameend=\"c9\" namest=\"c8\"\u003e \u003cp\u003e1.24 (1.23, 1.24)\u003csup\u003ea\u003c/sup\u003e\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colspan=\"3\" nameend=\"c12\" namest=\"c10\"\u003e \u003cp\u003e1.05 (1.04, 1.05)\u003csup\u003ea\u003c/sup\u003e\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colspan=\"3\" nameend=\"c15\" namest=\"c13\"\u003e\u0026nbsp;\u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c3\"\u003e \u003cp\u003e30\u0026thinsp;+\u0026thinsp;years\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colspan=\"2\" nameend=\"c7\" namest=\"c6\"\u003e \u003cp\u003e1.59 (1.58, 1.60)\u003csup\u003ea\u003c/sup\u003e\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colspan=\"2\" nameend=\"c9\" namest=\"c8\"\u003e \u003cp\u003e1.52 (1.51, 1.53)\u003csup\u003ea\u003c/sup\u003e\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colspan=\"3\" nameend=\"c12\" namest=\"c10\"\u003e \u003cp\u003e0.96 (0.96, 0.99)\u003csup\u003ea\u003c/sup\u003e\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colspan=\"3\" nameend=\"c15\" namest=\"c13\"\u003e\u0026nbsp;\u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c2\" morerows=\"1\" rowspan=\"2\"\u003e \u003cp\u003eCo-Occurring\u003c/p\u003e \u003cp\u003ePsychiatric Disorders\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c3\"\u003e \u003cp\u003eNo\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colspan=\"2\" morerows=\"1\" nameend=\"c5\" namest=\"c4\" rowspan=\"2\"\u003e \u003cp\u003e\u0026lt;\u0026thinsp;.001\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colspan=\"2\" nameend=\"c7\" namest=\"c6\"\u003e \u003cp\u003eREF\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colspan=\"2\" nameend=\"c9\" namest=\"c8\"\u003e \u003cp\u003eREF\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colspan=\"3\" nameend=\"c12\" namest=\"c10\"\u003e\u0026nbsp;\u003c/td\u003e \u003ctd align=\"left\" colspan=\"3\" nameend=\"c15\" namest=\"c13\"\u003e\u0026nbsp;\u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c3\"\u003e \u003cp\u003eYes\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colspan=\"2\" nameend=\"c7\" namest=\"c6\"\u003e \u003cp\u003e1.47 (1.47, 1.48)\u003csup\u003ea\u003c/sup\u003e\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colspan=\"2\" nameend=\"c9\" namest=\"c8\"\u003e \u003cp\u003e1.56 (1.55, 1.57)\u003csup\u003ea\u003c/sup\u003e\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colspan=\"3\" nameend=\"c12\" namest=\"c10\"\u003e \u003cp\u003e1.20 (1.20, 1.21)\u003csup\u003ea\u003c/sup\u003e\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colspan=\"3\" nameend=\"c15\" namest=\"c13\"\u003e\u0026nbsp;\u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c2\" morerows=\"2\" rowspan=\"3\"\u003e \u003cp\u003ePolysubstance Use\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c3\"\u003e \u003cp\u003e1 substance\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colspan=\"2\" morerows=\"2\" nameend=\"c5\" namest=\"c4\" rowspan=\"3\"\u003e \u003cp\u003e\u0026lt;\u0026thinsp;.001\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colspan=\"2\" nameend=\"c7\" namest=\"c6\"\u003e \u003cp\u003eREF\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colspan=\"2\" nameend=\"c9\" namest=\"c8\"\u003e \u003cp\u003eREF\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colspan=\"2\" nameend=\"c11\" namest=\"c10\"\u003e\u0026nbsp;\u003c/td\u003e \u003ctd align=\"left\" colspan=\"4\" nameend=\"c15\" namest=\"c12\"\u003e\u0026nbsp;\u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c3\"\u003e \u003cp\u003e2 substances\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colspan=\"2\" nameend=\"c7\" namest=\"c6\"\u003e \u003cp\u003e1.26 (1.25, 1.27)\u003csup\u003ea\u003c/sup\u003e\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colspan=\"2\" nameend=\"c9\" namest=\"c8\"\u003e \u003cp\u003e1.29 (1.28, 1.30)\u003csup\u003ea\u003c/sup\u003e\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colspan=\"4\" nameend=\"c13\" namest=\"c10\"\u003e \u003cp\u003e1.02 (1.01, 1.03)\u003csup\u003ea\u003c/sup\u003e\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colspan=\"2\" nameend=\"c15\" namest=\"c14\"\u003e\u0026nbsp;\u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c3\"\u003e \u003cp\u003e3 substances\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colspan=\"2\" nameend=\"c7\" namest=\"c6\"\u003e \u003cp\u003e1.41 (1.40, 1.42)\u003csup\u003ea\u003c/sup\u003e\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colspan=\"2\" nameend=\"c9\" namest=\"c8\"\u003e \u003cp\u003e1.53 (1.52, 1.54)\u003csup\u003ea\u003c/sup\u003e\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colspan=\"4\" nameend=\"c13\" namest=\"c10\"\u003e \u003cp\u003e1.08 (1.07, 1.09)\u003csup\u003ea\u003c/sup\u003e\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colspan=\"2\" nameend=\"c15\" namest=\"c14\"\u003e\u0026nbsp;\u003c/td\u003e \u003c/tr\u003e \u003c/tbody\u003e \u003c/colgroup\u003e \u003ctfoot\u003e \u003ctr\u003e\u003ctd colspan=\"15\"\u003eNote: Last column shows ORs for Predictor \u0026times; Sex interaction (F vs. M; M\u0026thinsp;=\u0026thinsp;REF); \u003cem\u003ea\u003c/em\u003e\u0026thinsp;=\u0026thinsp;p \u0026lt;\u0026thinsp;.01; \u003cem\u003eb\u003c/em\u003e\u0026thinsp;=\u0026thinsp;p \u0026gt;\u0026thinsp;.01; \u003cem\u003en.s.\u003c/em\u003e = no significant difference.\u003c/td\u003e\u003c/tr\u003e \u003c/tfoot\u003e \u003c/table\u003e\u003c/div\u003e \u003c/p\u003e \u003cp\u003e \u003cem\u003eSUD Severity-Related Predictors.\u003c/em\u003e Later onset of substance use, co-occurring psychiatric disorders, and polysubstance use were all associated with increased risk of treatment non-completion. Individuals who initiated substance use at age 30 or older had the highest likelihood of dropout, as did those reporting concurrent mental health diagnoses or using multiple substances at treatment admission. The strength of these associations varied by sex. Women showed greater risk related to psychiatric comorbidities and polysubstance use, while men exhibited greater risk when entering treatment after age 30. All results are reported in Table\u0026nbsp;\u003cspan refid=\"Tab3\" class=\"InternalRef\"\u003e3\u003c/span\u003e.\u003c/p\u003e"},{"header":"DISCUSSION","content":"\u003cp\u003eThis study examined how SDOH and SUD severity-related factors influence treatment outcomes in publicly funded SUD programs, with a focus on sex differences. Overall, we found that both SDOH and SUD severity indicators were strongly associated with substance use at discharge and treatment non-completion. Social and severity-related factors, such as unemployment, psychiatric comorbidity, and polysubstance use were consistently associated with poorer outcomes, especially for women. In contrast, fewer predictors, such as the lack of prior treatment, were more strongly associated with worse treatment outcomes in men, especially for substance use at discharge. These findings suggest that sex plays an important role in shaping how social and clinical vulnerabilities influence treatment outcomes.\u003c/p\u003e\n\u003ch3\u003eSDOH and Treatment Outcomes\u003c/h3\u003e\n\u003cp\u003eEconomic instability significantly impacted both substance use at discharge and treatment completion, with women more vulnerable to these effects. Unemployment was a consistent predictor of worse treatment outcomes across sexes, but the impact was stronger in women in both treatment outcomes. While employment is generally protective against treatment dropout for both men and women, women may be more vulnerable to the effects of unemployment due to compounded stressors including financial strain and caregiving responsibilities (Ogden, Dichter \u0026amp; Bazzi, \u003cspan citationid=\"CR25\" class=\"CitationRef\"\u003e2022\u003c/span\u003e; Greenfield et al., \u003cspan citationid=\"CR15\" class=\"CitationRef\"\u003e2007\u003c/span\u003e). These stressors may interfere with treatment retention and increase the likelihood of continued use.\u003c/p\u003e \u003cp\u003eSimilarly, educational attainment was protective against substance use at discharge; however, this also showed sex-differences in associations. Individuals with at least some college education had greater odds of substance use at discharge compared to those with a high school education or less, especially among men. Interestingly, this observation was in an unexpected direction given that higher education levels are typically associated with better health outcomes. However, this pattern may be reflective of heavier substance use among college-aged men, consistent with existing research (Iwamoto et al., \u003cspan citationid=\"CR16\" class=\"CitationRef\"\u003e2011\u003c/span\u003e). Nevertheless, the dataset used did not include direct information on substance use severity, limiting our ability to determine whether this association reflects pre-treatment use patterns.\u003c/p\u003e \u003cp\u003eHousing instability was associated with a decreased risk for treatment completion. While housing status did not significantly predict substance use at discharge, it was strongly associated with elevated dropout risk, especially among women. These findings reinforce the importance of housing stability for women to remain active in treatment programs (Kneck et al., \u003cspan citationid=\"CR19\" class=\"CitationRef\"\u003e2021\u003c/span\u003e), especially since unhoused women often face compounding structural and interpersonal barriers to care despite reporting high motivation to complete treatment (Upshur et al., \u003cspan citationid=\"CR39\" class=\"CitationRef\"\u003e2018\u003c/span\u003e).\u003c/p\u003e \u003cp\u003eHistory of recent arrests also impacted treatment outcomes, with specific sex differences emerging. Arrest history predicted continued substance use at discharge in both sexes, though the effect was stronger in women. This pattern aligns with existing literature demonstrating that legal system involvement often co-occurs with trauma, caregiving stress, and family system instability (Scott \u0026amp; Dennis, \u003cspan citationid=\"CR34\" class=\"CitationRef\"\u003e2012\u003c/span\u003e; Bloom et al., \u003cspan citationid=\"CR5\" class=\"CitationRef\"\u003e2003\u003c/span\u003e), factors that women are particularly sensitive to and thus may translate to poorer treatment outcomes in women. Additionally, recent arrests were more strongly associated with treatment dropout among men only. This is consistent with research that there is lower engagement in court-mandated care (Expósito-Álvarez et al., \u003cspan citationid=\"CR13\" class=\"CitationRef\"\u003e2023\u003c/span\u003e). For women, results suggest that while they were more compliant with attending treatment, they were nonetheless more likely to be using substances at discharge.\u003c/p\u003e \u003cp\u003eMarital status, used as an indicator of social support was associated with a slightly increased risk of treatment non-completion among unmarried individuals, with a statistically stronger effect in men, though the magnitude of this sex difference was modest. While marital status may not always reflect the presence or quality of social support (e.g. a partner may be emotionally unavailable or unsupportive), it can still serve as a general indicator of access to close relational social support. This may reflect sex differences in the availability and reliance on emotional support, as men are more likely to depend on romantic partners for support than women, who have broader social support networks outside their relationships (Wahring et al., \u003cspan citationid=\"CR40\" class=\"CitationRef\"\u003e2024\u003c/span\u003e).\u003c/p\u003e \u003cp\u003e \u003cstrong\u003eAccess to Treatment\u003c/strong\u003e \u003c/p\u003e\u003cp\u003eIndividuals entering treatment for the first time had higher odds of both treatment non-completion and substance use at discharge compared to those with prior treatment experience, with both outcomes more pronounced in men. However, the magnitude of the sex difference was small for treatment non-completion, while the effect on substance use at discharge was more substantial. These findings support the evidence that recovery is rarely linear, often requiring multiple episodes of care over time as individuals cycle through periods of substance use, treatment, and re-engagement (Dennis \u0026amp; Scott, \u003cspan citationid=\"CR12\" class=\"CitationRef\"\u003e2007\u003c/span\u003e). Health insurance coverage was a consistent protective factor across both treatment outcomes, though the strength of these associations varied slightly by sex. Compared to individuals without insurance coverage, those with private or public coverage had lower odds of substance use at discharge and were more likely to complete treatment. However, this protective effect was more pronounced in women related to substance use at discharge, while men showed slightly stronger benefits from private coverage in reducing dropout. These patterns may reflect reduced financial burden and continuity of care, as consistent health insurance coverage has shown to improve utilization of substance use, mental health and related services, especially among low-income adults with SUDs (Olfson et al., \u003cspan citationid=\"CR26\" class=\"CitationRef\"\u003e2022\u003c/span\u003e). These findings may reflect differences in treatment quality and consistency of care across the different funding sources, suggesting that access to well-funded care plans play an important role in supporting positive outcomes. Lastly, longer treatment duration was slightly protective against treatment non-completion, with stays of 31 days or more associated with reducing dropout risk in women. This pattern aligns with prior work showing that extended treatment is particularly beneficial in female-specific programs (Davis et al., \u003cspan citationid=\"CR11\" class=\"CitationRef\"\u003e2024\u003c/span\u003e).\u003c/p\u003e \u003cp\u003e\u003c/p\u003e \u003cdiv id=\"Sec8\" class=\"Section2\"\u003e \u003ch2\u003eSUD Severity-Related Predictors of Treatment Outcomes\u003c/h2\u003e \u003cp\u003eLater onset of substance use was associated with lower odds of substance use at discharge, particularly among men and women who initiated use between ages 18–29. This finding aligns with research showing that earlier initiation is associated with more severe and persistent substance use trajectories (Jordan \u0026amp; Andersen, \u003cspan citationid=\"CR17\" class=\"CitationRef\"\u003e2017\u003c/span\u003e; Poudel \u0026amp; Gautam, \u003cspan citationid=\"CR31\" class=\"CitationRef\"\u003e2017\u003c/span\u003e). In contrast, later age of substance use onset was associated with increased risk of treatment non-completion compared to early onset (\u0026lt; 17 years old), with the strongest effects observed among individuals whose use began at the age of 30 or older, in both men and women. For men, this may reflect entry into treatment in response to external pressures, such as job- or legal-related consequences, rather than intrinsic motivation to change (Weisner et al., \u003cspan citationid=\"CR41\" class=\"CitationRef\"\u003e2002\u003c/span\u003e). For women, life responsibilities, such as employment or family responsibilities, may interfere with their ability to remain in treatment over time (Greenfield et al., \u003cspan citationid=\"CR15\" class=\"CitationRef\"\u003e2007\u003c/span\u003e; Bloom et al., \u003cspan citationid=\"CR5\" class=\"CitationRef\"\u003e2003\u003c/span\u003e). Notably, this pattern may also reflect a broader public health trend of increasing substance use among older women, often in response to stress, isolation, or changing social roles (Patra et al., \u003cspan citationid=\"CR28\" class=\"CitationRef\"\u003e2024\u003c/span\u003e; Stelander et al., \u003cspan citationid=\"CR36\" class=\"CitationRef\"\u003e2021\u003c/span\u003e).\u003c/p\u003e \u003cp\u003ePolysubstance use predicted both substance use at discharge and non-completion, especially in women, with outcomes worsening as the number of substances increased. Women who reported using three substances had the highest likelihood of continued use and dropout, consistent with prior findings that polysubstance-using women often present with more complex clinical profiles, including co-occurring psychiatric conditions and poorer physical health compared to men (Rodriguez et al., \u003cspan citationid=\"CR33\" class=\"CitationRef\"\u003e2022\u003c/span\u003e; Moss et al., \u003cspan citationid=\"CR23\" class=\"CitationRef\"\u003e2015\u003c/span\u003e).\u003c/p\u003e \u003cp\u003eCo-occurring psychiatric disorders were associated with poorer treatment outcomes, particularly among women. This is highly consistent with prior research showing that women with SUDs are more likely to experience conditions such as depression, anxiety, and posttraumatic stress disorder (Chander \u0026amp; McCaul, \u003cspan citationid=\"CR8\" class=\"CitationRef\"\u003e2003\u003c/span\u003e; Zilberman et al., \u003cspan citationid=\"CR42\" class=\"CitationRef\"\u003e2003\u003c/span\u003e), which can complicate recovery and increase vulnerability to continued use even after treatment ends.\u003c/p\u003e \u003cp\u003e \u003cstrong\u003eClinical Implications\u003c/strong\u003e \u003c/p\u003e\u003cp\u003eThese findings emphasize the importance of tailoring SUD treatment approaches based on both SDOH and clinical severity, while accounting for sex-specific risk patterns. While several predictors, such as unemployment, psychiatric comorbidities and polysubstance use, were significant across sexes, women showed a more consistent pattern of vulnerability associated with poorer treatment outcomes. This suggests that more comprehensive treatment models, that incorporate trauma-informed care, stronger mental health support, and logistical support systems like childcare and transportation, may be especially beneficial for women. Among men, risk patterns varied more across predictors and treatment outcomes, but a history of prior treatment stood out as a consistent predictor associated with both substance use at discharge and treatment dropout. Although the sex difference in drop out related to prior treatment history was modest, this finding emphasizes the need for stronger engagement strategies for men entering treatment for the first time, especially for men entering treatment through external pressures. Programs may also benefit from fostering opportunities for men to build meaningful relationships, given our modest but significant findings related to marital status, and incorporating diversion-based to address criminal-legal system involvement. Designing treatment plans that respond to both real-world barriers and clinical needs, especially in ways that reflect the different challenges men and women face, will improve treatment retention and support sustained recovery.\u003c/p\u003e \u003cp\u003e\u003c/p\u003e \u003cp\u003e \u003cstrong\u003eLimitations and Future Directions\u003c/strong\u003e \u003c/p\u003e\u003cp\u003eThis study leveraged a large, nationally representative dataset to explore predictors of treatment outcomes in publicly funded SUD programs. While the dataset provided a substantial amount of information of treatment episodes, it was limited in the specificity of the available variables. Important psychosocial variables, such as treatment motivation, trauma history, perceived quality of care, quality of social support, and household responsibilities (e.g., childcare) were not captured, despite their well-established influence on recovery outcomes. Additionally, both substance use at discharge and treatment non-completion outcome variables were recoded using discharge codes rather than long-term behavioral outcomes, limiting insight into sustained recovery. Moreover, because the dataset only includes individuals who had already been discharged, it excludes those still in treatment and may not reflect the full range of treatment participation or continuity. Several predictors were also recoded into broader categorical variables, which may obscure within-group differences. Future research should incorporate more detailed, longitudinal designs, including post-discharge outcomes and stronger psychosocial data, to better understand recovery patterns and treatment engagement across sexes.\u003c/p\u003e \u003cp\u003e\u003c/p\u003e \u003cp\u003e\u003c/p\u003e \u003c/div\u003e"},{"header":"CONCLUSION","content":"\u003cp\u003eFindings from this study highlight the need for sex-informed approaches to SUD treatment that address both clinical severity and structural risk factors. Tailoring treatment approaches to reflect these distinct patterns may improve recovery outcomes. As treatment systems continue to evolve, integrating these insights can help close longstanding gaps in care and better support sustained recovery.\u003c/p\u003e"},{"header":"Declarations","content":"\u003cp\u003e\u003cstrong\u003eEthics Approval and Consent to Participate:\u003c/strong\u003e Not applicable.\u0026nbsp;\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003eConsent for Publication:\u003c/strong\u003e Not applicable.\u0026nbsp;\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003eData Availability:\u003c/strong\u003e Data is available upon reasonable request.\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003eCompeting Interests:\u003c/strong\u003e The authors declare no competing interests.\u0026nbsp;\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003eFunding:\u003c/strong\u003e Support provided by National Institutes of Health T32AA029259 (CLJC); U54AA027989 (SAM).\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003eAuthor Contributions:\u0026nbsp;\u003c/strong\u003eSAM and CLJC conceptualized the study. CLJC cleaned and analyzed the publicly available SAMHSA dataset, with statistical guidance from SAM. CLJC drafted the manuscript. All authors contributed to manuscript revisions, and SAM supervised the project.\u0026nbsp;\u003c/p\u003e"},{"header":"References","content":"\u003col\u003e\u003cli\u003e\u003cspan\u003eAcevedo A, Panas L, Garnick D, Acevedo-Garcia D, Miles J, Ritter G, Campbell K. Disparities in the Treatment of Substance Use Disorders: Does Where You Live Matter? J Behav Health Serv Res. 2018;45(4):533\u0026ndash;49. \u003cspan class=\"ExternalRef\"\u003e\u003cspan class=\"RefSource\"\u003ehttps://doi.org/10.1007/s11414-018-9586-y\u003c/span\u003e\u003cspan address=\"10.1007/s11414-018-9586-y\" targettype=\"DOI\" class=\"RefTarget\"\u003e\u003c/span\u003e\u003c/span\u003e.\u003c/span\u003e\u003c/li\u003e \u003cli\u003e\u003cspan\u003eAmaro H, Sanchez M, Bautista T, Cox R. Social vulnerabilities for substance use: Stressors, socially toxic environments, and discrimination and racism. Neuropharmacology. 2021;188:108518. \u003cspan class=\"ExternalRef\"\u003e\u003cspan class=\"RefSource\"\u003ehttps://doi.org/10.1016/j.neuropharm.2021.108518\u003c/span\u003e\u003cspan address=\"10.1016/j.neuropharm.2021.108518\" targettype=\"DOI\" class=\"RefTarget\"\u003e\u003c/span\u003e\u003c/span\u003e.\u003c/span\u003e\u003c/li\u003e \u003cli\u003e\u003cspan\u003eAndersson HW, Mosti MP, Nordfjaern T. Inpatients in substance use treatment with co-occurring psychiatric disorders: a prospective cohort study of characteristics and relapse predictors. BMC Psychiatry. 2023;23(1):152. \u003cspan class=\"ExternalRef\"\u003e\u003cspan class=\"RefSource\"\u003ehttps://doi.org/10.1186/s12888-023-04632-z\u003c/span\u003e\u003cspan address=\"10.1186/s12888-023-04632-z\" targettype=\"DOI\" class=\"RefTarget\"\u003e\u003c/span\u003e\u003c/span\u003e.\u003c/span\u003e\u003c/li\u003e \u003cli\u003e\u003cspan\u003eBhalla IP, Stefanovics EA, Rosenheck RA. Clinical Epidemiology of Single Versus Multiple Substance Use Disorders: Polysubstance Use Disorder. Med Care. 2017;55:S24\u0026ndash;32. \u003cspan class=\"ExternalRef\"\u003e\u003cspan class=\"RefSource\"\u003ehttps://doi.org/10.1097/MLR.0000000000000731\u003c/span\u003e\u003cspan address=\"10.1097/MLR.0000000000000731\" targettype=\"DOI\" class=\"RefTarget\"\u003e\u003c/span\u003e\u003c/span\u003e.\u003c/span\u003e\u003c/li\u003e \u003cli\u003e\u003cspan\u003eBloom B, Owen B, Covington S, Raeder M. Gender-Responsive Strategies: Research, Practice, and Guiding Principles for Women Offenders. Washington, DC: US Department of Justice, National Institute of Corrections; 2003.\u003c/span\u003e\u003c/li\u003e \u003cli\u003e\u003cspan\u003eCenters for Disease Control and Prevention (CDC). (2023). \u003cem\u003eSocial Determinants of Health: Know What Affects Health\u003c/em\u003e. Retrieved from \u003cspan class=\"ExternalRef\"\u003e\u003cspan class=\"RefSource\"\u003ehttps://www.cdc.gov/socialdeterminants\u003c/span\u003e\u003cspan address=\"https://www.cdc.gov/socialdeterminants\" targettype=\"URL\" class=\"RefTarget\"\u003e\u003c/span\u003e\u003c/span\u003e\u003c/span\u003e\u003c/li\u003e \u003cli\u003e\u003cspan\u003eChan B, Hoffman KA, Bougatsos C, Grusing S, Chou R, McCarty D. Mobile methadone medication units: A brief history, scoping review and research opportunity. J Subst Abuse Treat. 2021;129:108483. \u003cspan class=\"ExternalRef\"\u003e\u003cspan class=\"RefSource\"\u003ehttps://doi.org/10.1016/j.jsat.2021.108483\u003c/span\u003e\u003cspan address=\"10.1016/j.jsat.2021.108483\" targettype=\"DOI\" class=\"RefTarget\"\u003e\u003c/span\u003e\u003c/span\u003e.\u003c/span\u003e\u003c/li\u003e \u003cli\u003e\u003cspan\u003eChander G, McCaul ME. Co-occurring psychiatric disorders in women with addictions. Obstet Gynecol Clin N Am. 2003;30(3):469\u0026ndash;81. \u003cspan class=\"ExternalRef\"\u003e\u003cspan class=\"RefSource\"\u003ehttps://doi.org/10.1016/s0889-8545(03)00079-2\u003c/span\u003e\u003cspan address=\"10.1016/s0889-8545(03)00079-2\" targettype=\"DOI\" class=\"RefTarget\"\u003e\u003c/span\u003e\u003c/span\u003e.\u003c/span\u003e\u003c/li\u003e \u003cli\u003e\u003cspan\u003eChi FW, Weisner C, Grella CE, Hser YI, Moore C, Mertens J. Does age at first treatment episode make a difference in outcomes over 11 years? J Subst Abuse Treat. 2014;46(4):482\u0026ndash;90. \u003cspan class=\"ExternalRef\"\u003e\u003cspan class=\"RefSource\"\u003ehttps://doi.org/10.1016/j.jsat.2013.12.003\u003c/span\u003e\u003cspan address=\"10.1016/j.jsat.2013.12.003\" targettype=\"DOI\" class=\"RefTarget\"\u003e\u003c/span\u003e\u003c/span\u003e.\u003c/span\u003e\u003c/li\u003e \u003cli\u003e\u003cspan\u003eCoviello DM, Zanis DA, Wesnoski SA, Palman N, Gur A, Lynch KG, McKay JR. Does mandating offenders to treatment improve completion rates? J Subst Abuse Treat. 2013;44(4):417\u0026ndash;25. \u003cspan class=\"ExternalRef\"\u003e\u003cspan class=\"RefSource\"\u003ehttps://doi.org/10.1016/j.jsat.2012.10.003\u003c/span\u003e\u003cspan address=\"10.1016/j.jsat.2012.10.003\" targettype=\"DOI\" class=\"RefTarget\"\u003e\u003c/span\u003e\u003c/span\u003e.\u003c/span\u003e\u003c/li\u003e \u003cli\u003e\u003cspan\u003eDavis DW, Feygin Y, Shipley M, Hall TC, Downs C, Hoskins S, Pasquenza N, Duncan SD, Creel LM. A case report on a women's residential substance use program in a rural and urban setting. Matern Child Health J. 2024;28(11):1870\u0026ndash;5. \u003cspan class=\"ExternalRef\"\u003e\u003cspan class=\"RefSource\"\u003ehttps://doi.org/10.1007/s10995-024-03993-5\u003c/span\u003e\u003cspan address=\"10.1007/s10995-024-03993-5\" targettype=\"DOI\" class=\"RefTarget\"\u003e\u003c/span\u003e\u003c/span\u003e.\u003c/span\u003e\u003c/li\u003e \u003cli\u003e\u003cspan\u003eDennis M, Scott CK. Managing addiction as a chronic condition. Addict Sci Clin Pract. 2007;4(1):45\u0026ndash;55. \u003cspan class=\"ExternalRef\"\u003e\u003cspan class=\"RefSource\"\u003ehttps://doi.org/10.1151/ascp074145\u003c/span\u003e\u003cspan address=\"10.1151/ascp074145\" targettype=\"DOI\" class=\"RefTarget\"\u003e\u003c/span\u003e\u003c/span\u003e.\u003c/span\u003e\u003c/li\u003e \u003cli\u003e\u003cspan\u003eExp\u0026oacute;sito-\u0026Aacute;lvarez C, Santirso FA, Gilchrist G, Gracia E, Lila M. Participants in Court-mandated Intervention Programs for Intimate Partner Violence Perpetrators with Substance Use Problems: A Systematic Review of Specific Risk Factors. Psychosocial intervention. 2023;32(2):89\u0026ndash;108. \u003cspan class=\"ExternalRef\"\u003e\u003cspan class=\"RefSource\"\u003ehttps://doi.org/10.5093/pi2023a7\u003c/span\u003e\u003cspan address=\"10.5093/pi2023a7\" targettype=\"DOI\" class=\"RefTarget\"\u003e\u003c/span\u003e\u003c/span\u003e.\u003c/span\u003e\u003c/li\u003e \u003cli\u003e\u003cspan\u003eGoodwin SR, Moskal D, Marks RM, Clark AE, Squeglia LM, Roche DJO. A Scoping Review of Gender, Sex and Sexuality Differences in Polysubstance Use in Adolescents and Adults. Alcohol Alcohol. 2022;57(3):292\u0026ndash;321. \u003cspan class=\"ExternalRef\"\u003e\u003cspan class=\"RefSource\"\u003ehttps://doi.org/10.1093/alcalc/agac006\u003c/span\u003e\u003cspan address=\"10.1093/alcalc/agac006\" targettype=\"DOI\" class=\"RefTarget\"\u003e\u003c/span\u003e\u003c/span\u003e.\u003c/span\u003e\u003c/li\u003e \u003cli\u003e\u003cspan\u003eGreenfield SF, Brooks AJ, Gordon SM, Green CA, Kropp F, McHugh RK, Lincoln M, Hien D, Miele GM. Substance abuse treatment entry, retention, and outcome in women: a review of the literature. Drug Alcohol Depend. 2007;86(1):1\u0026ndash;21. \u003cspan class=\"ExternalRef\"\u003e\u003cspan class=\"RefSource\"\u003ehttps://doi.org/10.1016/j.drugalcdep.2006.05.012\u003c/span\u003e\u003cspan address=\"10.1016/j.drugalcdep.2006.05.012\" targettype=\"DOI\" class=\"RefTarget\"\u003e\u003c/span\u003e\u003c/span\u003e.\u003c/span\u003e\u003c/li\u003e \u003cli\u003e\u003cspan\u003eIwamoto DK, Cheng A, Lee CS, Takamatsu S, Gordon D. Man-ing up and getting drunk: the role of masculine norms, alcohol intoxication and alcohol-related problems among college men. Addict Behav. 2011;36(9):906\u0026ndash;11. \u003cspan class=\"ExternalRef\"\u003e\u003cspan class=\"RefSource\"\u003ehttps://doi.org/10.1016/j.addbeh.2011.04.005\u003c/span\u003e\u003cspan address=\"10.1016/j.addbeh.2011.04.005\" targettype=\"DOI\" class=\"RefTarget\"\u003e\u003c/span\u003e\u003c/span\u003e.\u003c/span\u003e\u003c/li\u003e \u003cli\u003e\u003cspan\u003eJordan CJ, Andersen SL. Sensitive periods of substance abuse: Early risk for the transition to dependence. Dev Cogn Neurosci. 2017;25:29\u0026ndash;44. \u003cspan class=\"ExternalRef\"\u003e\u003cspan class=\"RefSource\"\u003ehttps://doi.org/10.1016/j.dcn.2016.10.004\u003c/span\u003e\u003cspan address=\"10.1016/j.dcn.2016.10.004\" targettype=\"DOI\" class=\"RefTarget\"\u003e\u003c/span\u003e\u003c/span\u003e.\u003c/span\u003e\u003c/li\u003e \u003cli\u003e\u003cspan\u003eKeyes KM, Martins SS, Blanco C, Hasin DS. Telescoping and gender differences in alcohol dependence: new evidence from two national surveys. Am J Psychiatry. 2010;167(8):969\u0026ndash;76. \u003cspan class=\"ExternalRef\"\u003e\u003cspan class=\"RefSource\"\u003ehttps://doi.org/10.1176/appi.ajp.2009.09081161\u003c/span\u003e\u003cspan address=\"10.1176/appi.ajp.2009.09081161\" targettype=\"DOI\" class=\"RefTarget\"\u003e\u003c/span\u003e\u003c/span\u003e.\u003c/span\u003e\u003c/li\u003e \u003cli\u003e\u003cspan\u003eKneck \u0026Aring;, Mattsson E, Salzmann-Erikson M, Klarare A, in collaboration with Women Advisory Board for Inclusion Health. Stripped of dignity - Women in homelessness and their perspectives of healthcare services: A qualitative study. Int J Nurs Stud. 2021;120:103974. \u003cspan class=\"ExternalRef\"\u003e\u003cspan class=\"RefSource\"\u003ehttps://doi.org/10.1016/j.ijnurstu.2021.103974\u003c/span\u003e\u003cspan address=\"10.1016/j.ijnurstu.2021.103974\" targettype=\"DOI\" class=\"RefTarget\"\u003e\u003c/span\u003e\u003c/span\u003e.\u003c/span\u003e\u003c/li\u003e \u003cli\u003e\u003cspan\u003eKrawczyk N, Feder KA, Saloner B, Crum RM, Kealhofer M, Mojtabai R. The association of psychiatric comorbidity with treatment completion among clients admitted to substance use treatment programs in a U.S. national sample. Drug Alcohol Depend. 2017;175:157\u0026ndash;63. \u003cspan class=\"ExternalRef\"\u003e\u003cspan class=\"RefSource\"\u003ehttps://doi.org/10.1016/j.drugalcdep.2017.02.006\u003c/span\u003e\u003cspan address=\"10.1016/j.drugalcdep.2017.02.006\" targettype=\"DOI\" class=\"RefTarget\"\u003e\u003c/span\u003e\u003c/span\u003e.\u003c/span\u003e\u003c/li\u003e \u003cli\u003e\u003cspan\u003eLin C, Cousins SJ, Zhu Y, Clingan SE, Mooney LJ, Kan E, Wu F, Hser YI. A scoping review of social determinants of health's impact on substance use disorders over the life course. J Subst use Addict Treat. 2024;166:209484. \u003cspan class=\"ExternalRef\"\u003e\u003cspan class=\"RefSource\"\u003ehttps://doi.org/10.1016/j.josat.2024.209484\u003c/span\u003e\u003cspan address=\"10.1016/j.josat.2024.209484\" targettype=\"DOI\" class=\"RefTarget\"\u003e\u003c/span\u003e\u003c/span\u003e.\u003c/span\u003e\u003c/li\u003e \u003cli\u003e\u003cspan\u003eMcHugh RK, Votaw VR, Sugarman DE, Greenfield SF. Sex and gender differences in substance use disorders. Clin Psychol Rev. 2018;66:12\u0026ndash;23. \u003cspan class=\"ExternalRef\"\u003e\u003cspan class=\"RefSource\"\u003ehttps://doi.org/10.1016/j.cpr.2017.10.012\u003c/span\u003e\u003cspan address=\"10.1016/j.cpr.2017.10.012\" targettype=\"DOI\" class=\"RefTarget\"\u003e\u003c/span\u003e\u003c/span\u003e.\u003c/span\u003e\u003c/li\u003e \u003cli\u003e\u003cspan\u003eMoss HB, Goldstein RB, Chen CM, Yi HY. Patterns of use of other drugs among those with alcohol dependence: Associations with drinking behavior and psychopathology. Addict Behav. 2015;50:192\u0026ndash;8. \u003cspan class=\"ExternalRef\"\u003e\u003cspan class=\"RefSource\"\u003ehttps://doi.org/10.1016/j.addbeh.2015.06.041\u003c/span\u003e\u003cspan address=\"10.1016/j.addbeh.2015.06.041\" targettype=\"DOI\" class=\"RefTarget\"\u003e\u003c/span\u003e\u003c/span\u003e.\u003c/span\u003e\u003c/li\u003e \u003cli\u003e\u003cspan\u003eOffice of Disease Prevention and Health Promotion. Social determinants of health. U.S. Department of Health and Human Services; 2020. \u003cspan class=\"ExternalRef\"\u003e\u003cspan class=\"RefSource\"\u003ehttps://health.gov/healthypeople/priority-areas/social-determinants-health\u003c/span\u003e\u003cspan address=\"https://health.gov/healthypeople/priority-areas/social-determinants-health\" targettype=\"URL\" class=\"RefTarget\"\u003e\u003c/span\u003e\u003c/span\u003e.\u003c/span\u003e\u003c/li\u003e \u003cli\u003e\u003cspan\u003eOgden SN, Dichter ME, Bazzi AR. Intimate partner violence as a predictor of substance use outcomes among women: A systematic review. Addict Behav. 2022;127:107214. \u003cspan class=\"ExternalRef\"\u003e\u003cspan class=\"RefSource\"\u003ehttps://doi.org/10.1016/j.addbeh.2021.107214\u003c/span\u003e\u003cspan address=\"10.1016/j.addbeh.2021.107214\" targettype=\"DOI\" class=\"RefTarget\"\u003e\u003c/span\u003e\u003c/span\u003e.\u003c/span\u003e\u003c/li\u003e \u003cli\u003e\u003cspan\u003eOlfson M, Mauro C, Wall MM, Choi CJ, Barry CL, Mojtabai R. Healthcare coverage and service access for low-income adults with substance use disorders. J Subst Abuse Treat. 2022;137:108710. \u003cspan class=\"ExternalRef\"\u003e\u003cspan class=\"RefSource\"\u003ehttps://doi.org/10.1016/j.jsat.2021.108710\u003c/span\u003e\u003cspan address=\"10.1016/j.jsat.2021.108710\" targettype=\"DOI\" class=\"RefTarget\"\u003e\u003c/span\u003e\u003c/span\u003e.\u003c/span\u003e\u003c/li\u003e \u003cli\u003e\u003cspan\u003eParlier-Ahmad AB, Radic M, Svikis DS, Martin CE. Short communication: Relationship between social determinants and opioid use disorder treatment outcomes by gender. Drug Alcohol Depend. 2022;232:109337. \u003cspan class=\"ExternalRef\"\u003e\u003cspan class=\"RefSource\"\u003ehttps://doi.org/10.1016/j.drugalcdep.2022.109337\u003c/span\u003e\u003cspan address=\"10.1016/j.drugalcdep.2022.109337\" targettype=\"DOI\" class=\"RefTarget\"\u003e\u003c/span\u003e\u003c/span\u003e.\u003c/span\u003e\u003c/li\u003e \u003cli\u003e\u003cspan\u003ePatra S, Patra S, Das R, Patra SS. Rising Trend of Substance Abuse Among Older Adults: A Review Focusing on Screening and Management. Cureus. 2024;16(12):e76659. \u003cspan class=\"ExternalRef\"\u003e\u003cspan class=\"RefSource\"\u003ehttps://doi.org/10.7759/cureus.76659\u003c/span\u003e\u003cspan address=\"10.7759/cureus.76659\" targettype=\"DOI\" class=\"RefTarget\"\u003e\u003c/span\u003e\u003c/span\u003e.\u003c/span\u003e\u003c/li\u003e \u003cli\u003e\u003cspan\u003ePeacock A, Eastwood B, Jones A, Millar T, Horgan P, Knight J, Randhawa K, White M, Marsden J. Effectiveness of community psychosocial and pharmacological treatments for alcohol use disorder: A national observational cohort study in England. Drug Alcohol Depend. 2018;186:60\u0026ndash;7. \u003cspan class=\"ExternalRef\"\u003e\u003cspan class=\"RefSource\"\u003ehttps://doi.org/10.1016/j.drugalcdep.2018.01.019\u003c/span\u003e\u003cspan address=\"10.1016/j.drugalcdep.2018.01.019\" targettype=\"DOI\" class=\"RefTarget\"\u003e\u003c/span\u003e\u003c/span\u003e.\u003c/span\u003e\u003c/li\u003e \u003cli\u003e\u003cspan\u003ePolcin DL, Korcha R. Social Support Influences on Substance Abuse Outcomes Among Sober Living House Residents with Low and Moderate Psychiatric Severity. J alcohol drug Educ. 2017;61(1):51\u0026ndash;70.\u003c/span\u003e\u003c/li\u003e \u003cli\u003e\u003cspan\u003ePoudel A, Gautam S. Age of onset of substance use and psychosocial problems among individuals with substance use disorders. BMC Psychiatry. 2017;17(1):10. \u003cspan class=\"ExternalRef\"\u003e\u003cspan class=\"RefSource\"\u003ehttps://doi.org/10.1186/s12888-016-1191-0\u003c/span\u003e\u003cspan address=\"10.1186/s12888-016-1191-0\" targettype=\"DOI\" class=\"RefTarget\"\u003e\u003c/span\u003e\u003c/span\u003e.\u003c/span\u003e\u003c/li\u003e \u003cli\u003e\u003cspan\u003eRedeł A, Binkowska AA, Obarska K, Marcowski P, Szymczak K, Lewczuk K, Solich K, Banaszak M, Woronowicz B, Nowicka M, Skorko M, Gola M, Bielecki M. Evaluating the effectiveness of a mobile app-based self-guided psychological interventions to reduce relapse in substance use disorder: protocol for a randomized controlled trial. Front Psychiatry. 2024;15:1335105. \u003cspan class=\"ExternalRef\"\u003e\u003cspan class=\"RefSource\"\u003ehttps://doi.org/10.3389/fpsyt.2024.1335105\u003c/span\u003e\u003cspan address=\"10.3389/fpsyt.2024.1335105\" targettype=\"DOI\" class=\"RefTarget\"\u003e\u003c/span\u003e\u003c/span\u003e.\u003c/span\u003e\u003c/li\u003e \u003cli\u003e\u003cspan\u003eRodriguez AS, Robinson LD, Kelly PJ, Hudson S. Polysubstance use classes and health outcomes among women attending specialist substance use treatment services. Drug Alcohol Rev. 2022;41(2):488\u0026ndash;500. \u003cspan class=\"ExternalRef\"\u003e\u003cspan class=\"RefSource\"\u003ehttps://doi.org/10.1111/dar.13375\u003c/span\u003e\u003cspan address=\"10.1111/dar.13375\" targettype=\"DOI\" class=\"RefTarget\"\u003e\u003c/span\u003e\u003c/span\u003e.\u003c/span\u003e\u003c/li\u003e \u003cli\u003e\u003cspan\u003eScott CK, Dennis ML. The first 90 days following release from jail: findings from the Recovery Management Checkups for Women Offenders (RMCWO) experiment. Drug Alcohol Depend. 2012;125(1\u0026ndash;2):110\u0026ndash;8. \u003cspan class=\"ExternalRef\"\u003e\u003cspan class=\"RefSource\"\u003ehttps://doi.org/10.1016/j.drugalcdep.2012.03.025\u003c/span\u003e\u003cspan address=\"10.1016/j.drugalcdep.2012.03.025\" targettype=\"DOI\" class=\"RefTarget\"\u003e\u003c/span\u003e\u003c/span\u003e.\u003c/span\u003e\u003c/li\u003e \u003cli\u003e\u003cspan\u003eShaffer PM, Gaba A, Sprinckmoller SP, Starratt EL, Smelson DA. (2019). Treatment needs and gender differences among clients entering a rural drug treatment court with a co-occurring disorder. \u003cem\u003eDrug court review\u003c/em\u003e, \u003cem\u003e26\u003c/em\u003e.\u003c/span\u003e\u003c/li\u003e \u003cli\u003e\u003cspan\u003eStelander LT, H\u0026oslash;ye A, Bramness JG, Selb\u0026aelig;k G, Lunde LH, Wynn R, Gr\u0026oslash;nli OK. (2021). The changing alcohol drinking patterns among older adults show that women are closing the gender gap in more frequent drinking: the Troms\u0026oslash; study, 1994\u0026ndash;2016. \u003cem\u003eSubstance abuse treatment, prevention, and policy\u003c/em\u003e, \u003cem\u003e16\u003c/em\u003e(1), 45. \u003cspan class=\"ExternalRef\"\u003e\u003cspan class=\"RefSource\"\u003ehttps://doi.org/10.1186/s13011-021-00376-9\u003c/span\u003e\u003cspan address=\"10.1186/s13011-021-00376-9\" targettype=\"DOI\" class=\"RefTarget\"\u003e\u003c/span\u003e\u003c/span\u003e\u003c/span\u003e\u003c/li\u003e \u003cli\u003e\u003cspan\u003eSubstance Abuse and Mental Health Services Administration (SAMHSA). (2024). \u003cem\u003eKey substance use and mental health indicators in the united states: Results from the 2023 National Survey on Drug Use and Health\u003c/em\u003e [Report].\u003c/span\u003e\u003c/li\u003e \u003cli\u003e\u003cspan\u003eTowers EB, Williams IL, Qillawala EI, Rissman EF, Lynch WJ. Sex/Gender Differences in the Time-Course for the Development of Substance Use Disorder: A Focus on the Telescoping Effect. Pharmacol Rev. 2023;75(2):217\u0026ndash;49. \u003cspan class=\"ExternalRef\"\u003e\u003cspan class=\"RefSource\"\u003ehttps://doi.org/10.1124/pharmrev.121.000361\u003c/span\u003e\u003cspan address=\"10.1124/pharmrev.121.000361\" targettype=\"DOI\" class=\"RefTarget\"\u003e\u003c/span\u003e\u003c/span\u003e.\u003c/span\u003e\u003c/li\u003e \u003cli\u003e\u003cspan\u003eUpshur CC, Jenkins D, Weinreb L, Gelberg L, Orvek EA. Homeless women's service use, barriers, and motivation for participating in substance use treatment. Am J Drug Alcohol Abus. 2018;44(2):252\u0026ndash;62. \u003cspan class=\"ExternalRef\"\u003e\u003cspan class=\"RefSource\"\u003ehttps://doi.org/10.1080/00952990.2017.1357183\u003c/span\u003e\u003cspan address=\"10.1080/00952990.2017.1357183\" targettype=\"DOI\" class=\"RefTarget\"\u003e\u003c/span\u003e\u003c/span\u003e.\u003c/span\u003e\u003c/li\u003e \u003cli\u003e\u003cspan\u003eWahring IV, Simpson JA, Van Lange PAM. Romantic Relationships Matter More to Men than to Women. Behav Brain Sci. 2024;1\u0026ndash;64. \u003cspan class=\"ExternalRef\"\u003e\u003cspan class=\"RefSource\"\u003ehttps://doi.org/10.1017/S0140525X24001365\u003c/span\u003e\u003cspan address=\"10.1017/S0140525X24001365\" targettype=\"DOI\" class=\"RefTarget\"\u003e\u003c/span\u003e\u003c/span\u003e. Advance online publication.\u003c/span\u003e\u003c/li\u003e \u003cli\u003e\u003cspan\u003eWeisner C, Matzger H, Tam T, Schmidt L. Who goes to alcohol and drug treatment? Understanding utilization within the context of insurance. J Stud Alcohol. 2002;63(6):673\u0026ndash;82. \u003cspan class=\"ExternalRef\"\u003e\u003cspan class=\"RefSource\"\u003ehttps://doi.org/10.15288/jsa.2002.63.673\u003c/span\u003e\u003cspan address=\"10.15288/jsa.2002.63.673\" targettype=\"DOI\" class=\"RefTarget\"\u003e\u003c/span\u003e\u003c/span\u003e.\u003c/span\u003e\u003c/li\u003e \u003cli\u003e\u003cspan\u003eZilberman ML, Tavares H, Blume SB, el-Guebaly N. Substance use disorders: sex differences and psychiatric comorbidities. Can J Psychiatry. 2003;48(1):5\u0026ndash;13. \u003cspan class=\"ExternalRef\"\u003e\u003cspan class=\"RefSource\"\u003ehttps://doi.org/10.1177/070674370304800103\u003c/span\u003e\u003cspan address=\"10.1177/070674370304800103\" targettype=\"DOI\" class=\"RefTarget\"\u003e\u003c/span\u003e\u003c/span\u003e.\u003c/span\u003e\u003c/li\u003e\u003c/ol\u003e"}],"fulltextSource":"","fullText":"","funders":[],"hasAdminPriorityOnWorkflow":false,"hasManuscriptDocX":true,"hasOptedInToPreprint":true,"hasPassedJournalQc":"","hasAnyPriority":false,"hideJournal":false,"highlight":"","institution":"","isAcceptedByJournal":true,"isAuthorSuppliedPdf":false,"isDeskRejected":"","isHiddenFromSearch":false,"isInQc":false,"isInWorkflow":false,"isPdf":false,"isPdfUpToDate":true,"isWithdrawnOrRetracted":false,"journal":{"display":true,"email":"
[email protected]","identity":"biology-of-sex-differences","isNatureJournal":false,"hasQc":true,"allowDirectSubmit":false,"externalIdentity":"bosd","sideBox":"Learn more about [Biology of Sex Differences](http://bsd.biomedcentral.com)","snPcode":"13293","submissionUrl":"https://submission.nature.com/new-submission/13293/3","title":"Biology of Sex Differences","twitterHandle":"@BiologySexDiff","acdcEnabled":true,"dfaEnabled":true,"editorialSystem":"stoa","reportingPortfolio":"BMC/SO AJ","inReviewEnabled":true,"inReviewRevisionsEnabled":true},"keywords":"Sex Differences, Social Determinants of Health, Substance Use Disorder, Treatment Outcomes, Community Treatment","lastPublishedDoi":"10.21203/rs.3.rs-6422698/v1","lastPublishedDoiUrl":"https://doi.org/10.21203/rs.3.rs-6422698/v1","license":{"name":"CC BY 4.0","url":"https://creativecommons.org/licenses/by/4.0/"},"manuscriptAbstract":"\u003cp\u003e\u003cstrong\u003eBackground:\u003c/strong\u003e Social determinants of health (SDOH) and clinical severity factors are known to shape substance use disorder (SUD) treatment outcomes, yet limited research has explored how these influences differ by sex. Understanding these differences is important to improving treatment equity and outcomes in publicly funded treatment systems.\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003eMethods:\u003c/strong\u003e This study analyzed data from the 2018–2022 Treatment Episode Data Set – Discharges (TEDS-D), a national dataset of adults discharged from publicly funded SUD treatment programs. Sex-stratified binary logistic regressions were used to examine predictors of two outcomes: treatment non-completion and substance use at discharge. Predictors included SDOH (i.e., employment, education level, housing status, criminal justice involvement, prior treatment history, marital status, health insurance coverage and treatment duration) and indicators of SUD severity (e.g., age at first use, polysubstance use, and co-occurring psychiatric disorders).\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003eResults:\u003c/strong\u003e Both SDOH and clinical severity indicators were significantly associated with poorer treatment outcomes, with distinct patterns by sex. Women showed more consistent risk for poor treatment outcomes across predictors, including unemployment, psychiatric comorbidities, and polysubstance use, while lack of prior treatment history was the strongest predictor of substance use at discharge and dropout for men. Other predictors, such as housing instability, criminal justice involvement, and later-onset substance use, were also associated with increased risk of non-abstinence and dropout, with notable sex differences. Health insurance coverage was associated with better outcomes for both sexes, with the protective effect more consistent in women.\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003eConclusions:\u003c/strong\u003e These findings emphasize the need for sex-informed treatment approaches that address both social determinants of health and clinical complexity. Tailoring care to the unique risks and contexts of men and women may improve retention and reduce substance use at discharge, particularly in publicly funded systems.\u003c/p\u003e","manuscriptTitle":"Sex Differences in the Impact of Social Determinants of Health on Substance Use Disorder Treatment Outcomes","msid":"","msnumber":"","nonDraftVersions":[{"code":1,"date":"2025-04-30 11:46:44","doi":"10.21203/rs.3.rs-6422698/v1","editorialEvents":[{"type":"communityComments","content":0},{"type":"decision","content":"Revision requested","date":"2025-06-12T18:50:13+00:00","index":"","fulltext":""},{"type":"editorInvitedReview","content":"","date":"2025-05-26T20:08:45+00:00","index":"hide","fulltext":""},{"type":"reviewerAgreed","content":"161614212416708592166126090812792030677","date":"2025-05-08T15:08:48+00:00","index":"hide","fulltext":""},{"type":"reviewersInvited","content":"","date":"2025-04-28T15:32:54+00:00","index":"","fulltext":""},{"type":"editorAssigned","content":"","date":"2025-04-15T13:49:41+00:00","index":"","fulltext":""},{"type":"checksComplete","content":"","date":"2025-04-15T13:49:36+00:00","index":"","fulltext":""},{"type":"submitted","content":"Biology of Sex Differences","date":"2025-04-10T18:51:04+00:00","index":"","fulltext":""}],"status":"published","journal":{"display":true,"email":"
[email protected]","identity":"biology-of-sex-differences","isNatureJournal":false,"hasQc":true,"allowDirectSubmit":false,"externalIdentity":"bosd","sideBox":"Learn more about [Biology of Sex Differences](http://bsd.biomedcentral.com)","snPcode":"13293","submissionUrl":"https://submission.nature.com/new-submission/13293/3","title":"Biology of Sex Differences","twitterHandle":"@BiologySexDiff","acdcEnabled":true,"dfaEnabled":true,"editorialSystem":"stoa","reportingPortfolio":"BMC/SO AJ","inReviewEnabled":true,"inReviewRevisionsEnabled":true}}],"origin":"","ownerIdentity":"eb66d5e1-55df-4337-af44-68dc03497164","owner":[],"postedDate":"April 30th, 2025","published":true,"recentEditorialEvents":[],"rejectedJournal":[],"revision":"","amendment":"","status":"published-in-journal","subjectAreas":[],"tags":[],"updatedAt":"2025-07-28T16:02:28+00:00","versionOfRecord":{"articleIdentity":"rs-6422698","link":"https://doi.org/10.1186/s13293-025-00734-3","journal":{"identity":"biology-of-sex-differences","isVorOnly":false,"title":"Biology of Sex Differences"},"publishedOn":"2025-07-22 15:57:54","publishedOnDateReadable":"July 22nd, 2025"},"versionCreatedAt":"2025-04-30 11:46:44","video":"","vorDoi":"10.1186/s13293-025-00734-3","vorDoiUrl":"https://doi.org/10.1186/s13293-025-00734-3","workflowStages":[]},"version":"v1","identity":"rs-6422698","journalConfig":"researchsquare"},"__N_SSP":true},"page":"/article/[identity]/[[...version]]","query":{"redirect":"/article/rs-6422698","identity":"rs-6422698","version":["v1"]},"buildId":"8U1c8b4HqxoKbykW_rLl7","isFallback":false,"isExperimentalCompile":false,"dynamicIds":[84888],"gssp":true,"scriptLoader":[]}
Text is read by the "Ask this paper" AI Q&A widget below.
Extraction quality varies by source — PMC NXML preserves structure
cleanly, OA-HTML may include some navigation residue, and OA-PDF can
have broken hyphenation. The publisher copy
(via DOI)
is the canonical version.